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 I 
AIDS is a disease. It is an infection, a syndrome, an illness, a disorder, a 
condition threatening to human life. It is an epidemic- a social crisis, an 
economic catastrophe, a political challenge, a human disaster. AIDS is known. 
It has been analysed assessed assayed tested measured surveyed considered 
reflected documented depicted exhaustively described. Its virus is primal 
particular sub- cellular, mutant enveloped nitrogenous. Our knowledge of it is 
clear and precise. But the disease is also unknown. It is guessed estimated 
projected approximated sketched debated disputed controverted hidden 
obscured. Still, it is mere fact: an event, a circumstance, a happening, a reality 
as present as the ocean or the moon.  
 
AIDS is mouth and tongue and scar and nerve and eye and brain and skin and 
tum and gut. AIDS is smell and feel- of sweat and grime and snot and breath 
and bowel and secretion, discharge, pus, putrescence, disintegration, 
excrement, waste. Human waste. AIDS is feeling- painful sharp tingling burning 
heavy dull weakening wasting enervating diminishing destroying bereaving. 
AIDS is fear. It is breathless and nameless. 
AIDS is stigma disgrace discrimination hatred hardship abandonment isolation 
exclusion prohibition persecution poverty privation.  
AIDS is a metaphor. It is a threat a tragedy a blight a blot a scar a stain a 
plague a scourge a pestilence a demon killer rampant rampaging murderer. It is 
made moral. It is condemnation deterrence retribution punishment, a sin a 
lesson a curse rebuke judgement. It is a disease. 
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1. Background & Objective 
 
Human immunodeficiency Virus (HIV)/ acquired immunodeficiency syndrome 
(AIDS) is now the single leading infectious cause of death in developing 
countries. According to data of the United Nations programme on HIV/ AIDS 
(UNAIDS) [UNAIDS, 2007] the estimated number of people living with HIV 
worldwide in 2007 was 33.2 million (30.6- 36.2 million people), 2.5 million (1.8- 
4.1 million) became infected and 2.1 million (1.9- 2.4 million) people died with 
AIDS. 68% of all adults and 90% of all children suffering from AIDS globally live 
in the sub- Saharan Africa and 76% of all deaths due to AIDS in 2007 occurred 
there. Worldwide more adult women (15 years and older) than ever before are 
now living with HIV. 
 
Two major challenges for developing countries are the prevention of 
heterosexual transmission of HIV and the prevention of mother to child 
transmission of the virus. HIV can be transferred from an infected mother to her 
infant before or during birth, or after birth through breastfeeding. Mother to 
infant transmission (MTCT) is also known as “perinatal transmission” or “vertical 
transmission”. Vertical transmission transfers the virus from one generation to 
the next. Worldwide it is the second most common form of HIV transmission 
after sexual transmission. 
Various facts, like the viral load of the mother, the way of birth, the maternal 
immune and nutritional status and the breastfeeding duration and pattern have 
an important impact on vertical transmission.  
Zn and Se are important immune- modulators in human body and thus may be 
critical in determining the outcome of MTCT via breastfeeding. 
 
Therefore, the objective of this study was to get information about 
sociodemographic data (questionnaire), the breast feeding pattern, the general 
nutritional situation (24-h-recalls) and the status of Se and Zn assessed by the 
activities of erythrocyte glutathione peroxidase (GSH-Px) and superoxide 
dismutase (SOD) and its impact on MTCT in lactating Kenyan women. 
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2. Literature Review 
 
2.1. HIV/ AIDS 
 
Human immunodeficiency Virus (HIV)/ acquired immunodeficiency syndrome 
(AIDS) is now the single leading infectious cause of death in developing 
countries. The United Nations programme on HIV/ AIDS (UNAIDS) published in 
2007 statistics about HIV infections, new infections and AIDS deaths [UNAIDS, 
2007]. In 2007 the estimated number of people living with HIV worldwide was 
33.2 million (30.6 - 36.2 million people), 2.5 million (1.8 - 4.1 million) became 
infected and 2.1 million (1.9 - 2.4 million) people died with AIDS. 68% of all 
adults and 90% of all children suffering from AIDS globally live in the sub- 
Saharan Africa and 76% of all deaths due to AIDS in 2007 occurred there. 
Globally more adult women (15 years and older) than ever before are now living 
with HIV. In sub- Saharan Africa for every ten adult men living with HIV, there 
are about 14 women living with HIV. Young women (15 - 24 years) are four 
times more likely to be HIV infected than young men.  
The AIDS epidemic has a major demographic impact on many countries were 
the prevalence of HIV is high and this effects include an overall reduction in life 
expectancy, a decline in child survival and an increase in orphans [SEMBA and 
BLOEM, 2001].  
Two major challenges for developing countries are the prevention of 
heterosexual transmission of HIV and the prevention of mother to child 
transmission of HIV. HIV can be transferred from an infected mother to her 
infant before or during birth, or after birth through breastfeeding. Mother to child 
transmission (MTCT) is also known as “perinatal transmission” or “vertical 
transmission”. Vertical transmission transfers the virus from one generation to 
the next. MTCT of HIV is thought to occur in 15% of births to HIV positive 
women. Worldwide it is the second most common form of HIV transmission 
after sexual transmission. A strong correlation was found between levels of free 
virus in the mother’s blood and vertical transmission. But there are some more 
factors, which can lead to MTCT:  
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 Maternal Immune Status. A low CD4+ count is associated with an 
increased risk of perinatal transmission 
 Maternal Nutritional Status. Vitamin A deficiency. In Africa, vitamin A 
deficiency in pregnant women appears to increase the risk of perinatal 
transmission. However, it is not known yet whether supplements of 
vitamin A reduce this risk.  
 Breastfeeding duration and pattern 
 Maternal viral load 
 Prolonged period between the time when the mother’s water breaks and 
the time of delivery 
 Presence of ulcerations in the mother caused by sexually transmitted 
infections 
 Vaginal delivery. Some studies suggest that vaginal delivery increases 
the risk of transmission, but this has not been conclusively shown, and 
cesarian sections are not recommended as means of reducing the risk of 
HIV transmission. 
 
In resource poor settings in Africa, breast milk is an important source of energy 
and protein for the first two years of life. It reduces the incidence and severity of 
infectious diseases, thereby lowering infant morbidity and mortality.  
Guidelines on breastfeeding with HIV, prepared jointly by UNAIDS, WHO and 
UNICEF, recommend that breastfeeding should be protected, promoted and 
supported among HIV negative mothers and mothers of unknown infection 
status. These guidelines furthermore promote fully informed, free choice of 
infant feeding methods for HIV positive mothers, but introduce artificial feeding 
as a viable alternative to breastfeeding. This has led to a heated debate 
regarding the breastfeeding method in resource poor settings for infants whose 
mothers are infected with HIV. Mothers get confronted with contradictory 
messages:  
Breast milk as the best form of infant feeding and breast milk as a source of a 
deadly virus.  
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A WHO conducted metaanalysis [UNAIDS, UNICEF, WHO, 2006] of data from 
developing countries showed that mortality from diarrhoea, acute respiratory 
infections and other infectious illness is five to six times higher in infants who 
are not breastfed than those who are breastfed for the first months of life. The 
infant will run a higher risk to die from infectious disease, than from HIV infected 
mothers during breastfeeding. Support for exclusive breastfeeding has also 
come from a study in Kisumu, Kenya. In this study, the incidence of HIV 
infection was greater for infants who started mixed breast feeding before 30 
days than for infants who started mixed breast feeding after 30 days. The 
effects of viral load and severity of maternal illness were not factored into the 
results [THOMAS et al., 2005]. 
 
2.2. Micronutrients, Malnutrition and HIV 
 
2.2.1. Nutrition in Developing Countries 
 
In developing countries the main food are cereals such as maize, rice, wheat, 
sorghum, millet, tubers or legumes, which comprise 70% of the energy intake 
[CHANDRA, 1992]. Small amounts of vegetables and fruits are part of the diet 
as well as animal products. In general, the diet is low in energy and nutrient 
density. Severe micronutrient deficiencies often occur as multiple deficiencies 
and coexist with protein- energy malnutrition. In addition, the bioavailability of 
some vitamins and minerals are low too, e.g. cereals have a high content of 
phytate, which bind Zn, non- heme Fe and other minerals in the intestinal tract, 
thus preventing their absorption. To change the nutritional situation in 
developing countries unconditional commitment from not only health planners, 
but also from politicians is required to ensure multisectoral collaboration and the 
simultaneous use of several interventions such as plant breeding for higher 
micronutrient density, food diversification, food fortification, infectious disease 
control and micronutrient supplementation. 
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People living in developing countries suffer more often from diarrhoea, 
respiratory tract infections and harbour commonly several parasites. Most 
micronutrients such as vitamin A, beta-carotene, folic acid, vitamin B12, vitamin 
C, riboflavin, Fe, Zn and Se are significant immune- modulators and thus critical 
in determining the outcome of host microbe interactions [BHASKARAM, 2002]. 
Most generalized infections lead to reduced food intake and absorption of 
nutrients and increased utilization and loss of nutrients. The nutritional status of 
an individual may affect exposure to infectious agents, susceptibility to infection 
and in particular the severity and duration of the infection. It may even affect the 
virulence of an infectious agent. Vitamin and mineral deficiencies may lead to 
oxidative stress and result in increased apoptosis of immune cells and 
increased morbidity. 
 
2.2.2. Micronutrients and HIV/ AIDS 
 
Several general factors such as micronutrients can contribute to the deficiency 
of trace elements in the HIV infection. The supply can be diminished through 
loss of appetite and dysphagia, but also malabsorption and diarrhoea contribute 
to the inadequate status of trace elements. Cu, Fe, Se (see 2.4) and Zn (see 
2.5) are most frequent concerned trace elements. While the status of Fe, Se 
and Zn have been noticed to be lower in HIV positive than HIV negative people, 
plasma concentrations of Cu tend to be increased in presence of HIV infection 
[CAMPERA, 1999]. This was clearly shown in a study carried out with pregnant 
HIV positive women and a mixed group of HIV positive adults [OBI et al., 1997; 
MORENO et al., 1998].  
 
During the infection malabsorption of Fe, folates and vitamin B12 can often be 
observed. Serum Fe, transferrin and haemoglobin have been noted to be 
decreased, while ferritine, which could be an independent marker of infection 
progression, has been increase.  
A marginal status or deficiency of micronutrients can lead to more frequent 
infections with cytomegalovirus or pneymocystis carinii in HIV patients. 
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Furthermore, HIV negatively modulates the expression of transferrin receptors 
on lymphoid cell membranes which seems to be parallel to the 
cytopathogenicity of the virus [SAVARINO et al., 2000]. The metabolism of Fe 
plays an important role on disease progression and morbidity and the 
accumulation of Fe seems associated with shorter survival. 
A prospective cohort study from Rwanda reported that HIV infected women with 
low serum vitamin A concentrations during pregnancy were more likely than 
were women with normal vitamin A concentrations to have an infant who was 
HIV positive [GRAHAM et al., 1993]. However, it has to be considered, that HIV 
infection could lead to vitamin A deficiency by adversely affecting nutrient 
absorption and metabolism. Furthermore, serum retinol is depressed during 
acute phase response to infection, even when liver stores are adequate 
[FILTEAU et al, 1993]. 
 
2.3. Breastfeeding 
 
Breastfeeding is the natural way of feeding infants and young children. 
Exclusive breastfeeding for the first six months of life ensures optimal growth, 
development and health of the baby. After six months, breastfeeding with 
appropriate complementary food continues to contribute on the infants and 
young children growth, development and health. Low rates and early cessation 
of breastfeeding have important adverse effects on health, social and economic 
implications for women, children, the community and the environment [LEON- 
CAVER et al., 2002; BRYCE et al., 2003].  
Newborns are high susceptible to infections during early life, because of the late 
development of the immune system. Neutrophile functions, macrophage 
activation by interferon (IF)- , formation of T-cells, immunglobulin (Ig)G 
antibody to T-cell independent immunogens and complement components have 
all been noted to be at a low level during early infancy [GOLDMAN et al., 1997]. 
Newborns produce lower amounts of many cytokines, including granulocyte-/ 
macrophage colony stimulating factor, IF- , interleukin (IL)-3, IL-4, IL-6, and 
tumor necrosis factor (TNF)-  than adults [LÖNNERDAL, 2000].  
LITERATURE REVIEW 
 7 
There is significant evidence for infants in developing countries, that 
breastfeeding prevents infections. Several investigations indicate that the 
incidence and prevalence of illness is considerably lower in breastfed infants 
than in infants fed other diets. Breast milk contains several components that 
directly participate in the immune function of the breastfed infant. Many 
components interact directly with immune factors in the breast milk or more 
indirectly affect its responsiveness and activity. This includes cells as well as 
soluble substances in breast milk. Furthermore it should be recognized that 
breast milk provides a very balanced supply of nutrients to the infant. 
 
2.3.1. Breastfeeding, MTCT and Micronutrients 
 
Breastfeeding, source of high quality nutrients and as a mean of promoting 
protection from common infections, is widely practiced during the first two years 
of life in sub- Saharan African countries. Nursing and HIV positive mothers are 
still a very controversial issue, but the WHO/ UNICEF expert consultation and 
others have concluded that in situations such as those prevailing in sub- 
Saharan Africa, where infectious diseases and malnutrition are the major 
causes of the extraordinary high infant mortality rate, breastfeeding should be 
encouraged regardless of maternal HIV status [WHO, 1992] [DUNN and 
NEWELL et al., 1992].  
 
Immunological active breast milk components 
There are many specific and non- specific immunologic factors in human breast 
milk (s.2.1.), which may protect against HIV infection in infants. Among 18 
months old infants of HIV infected women in Rwanda, a lack of persistence of 
IgM in breast milk increased the risk of infant HIV infection [VAN DE PERRE, 
1993].  
Lactoferrin from breast milk showed anti- HIV effects in vitro by binding the V3 
domain of the HIV envelope protein gp120 [SWART, 1998]. Also 
glykosaminoglycanes and chemokines contained in breast milk do have 
defence duties in the infant´s organism.  
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Many of these immunological properties of human breast milk and its nutritional 
quality are connected to the nutritional status of the mother.  
 
Influence of micronutrients on MTCT 
There is evidence that micronutrient deficiencies may be important co factors in 
HIV progression and transmission [FRIIS and MICHAELSEN, 1998; SEMBA 
and TANG, 1999]. An inadequate micronutrient status of HIV/ AIDS infected 
women can lead to numerous adverse biological mechanisms (Fehler! 
Verweisquelle konnte nicht gefunden werden.). 
 
Table 1: Potential relations between micronutrient deficiency and MTCT 
[Mod.: DREYFUSS and FAWZI, 2002] 
Maternal factors  Progression of HIV disease 
 Cellular and humoral immunity 
 Systemic viral load 
 Clinical progression and opportunistic infections 
Breast  Mucosal immunity 
 Epithelial integrity 
 Systemic viral load 
Child factors  Birth weight 
 Preterm birth 
 Gastrointestinal epithelial integrity 
Cellular and humoral immunity 
... increased, ... decreased 
 
 
In 1986 The University of Nairobi carried out a study on MTCT. The study was 
initiated to determine the frequency, timing and routes of HIV- 1 transmission, 
identify the risk factors resulting in increased transmission and to identify 
potential interventions to prevent it [EMBREE et al., 2000]. In the study neither 
mothers nor children received specific antiretroviral therapy. The occurrence of 
maternal mastitis and the presence of nipple lesions during breastfeeding were 
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each associated with an increased risk of postpartum transmission of HIV-1. 
Breast and nipple lesions were not more common among HIV-1 infected women 
than in a concomitantly enrolled cohort of HIV-1 uninfected mothers. In the 
Kenyan study breastfeeding for longer than 15 months was associated with an 
increased risk of HIV-1 postnatal transmission. Children were more likely to 
become infected if the mother seroconverted while breastfeeding (Fehler! 
Verweisquelle konnte nicht gefunden werden.). EMBREE et al., [2000] 
suggested to all women who were known to be HIV-1 seropositive and who 
were impelled to breastfeed, should be given advice to wean their infants as 
early as they can. The issue of the potential protective effect of exclusive 
breastfeeding without supplemental feedings during the period of breastfeeding 
remained to be confirmed [COUTSOUDIS et al., 1999]. 
 
Table 2: Ultimate HIV-1 status in children of HIV-1 infected women 
[Mod.: EMBREE JE et al., 2000] 
 Child HIV-1 
uninfected 
Child HIV-1 
prenatal  
infected 
Child HIV-1 
postnatal 
infected 
HIV-1 infected women  
at delivery 
310 51 37 
HIV-1 seroconverting women 
during follow up 
7 0 5 
Total number of children 
 
317 51 42 
 
 
In a randomized trial comparing breastfeeding and formula feeding among HIV-
1 infected women, breastfed and formula fed infants had similar mortality rates 
after two years (frequent cause of death: pneumonia and diarrhoea). However, 
formula fed infants tended to have an increased risk of diarrhoea during the first 
three months of life while breastfed infants had better nutritional status during 
the first six months of life. The final conclusion was that infants, which were fed 
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with formula food, had a significant higher HIV-1 free survival at two years 
[NDUATI et al, 2001].  
Comparable mortality rates between the breastfed and the formula fed infants of 
HIV positive women were also observed in another study [NDUATI et al., 2000]. 
Further, this investigation showed that in the first place the estimated rate of 
breast milk HIV-1 transmission was 16.2% during the first two years of life. 
Given an HIV-1 infection rate of 36.7% in the breastfeeding arm, breast milk 
transmission accounted for 44% of all infant infections among those exposed to 
breast milk. Moreover, the timing of breast milk and HIV-1 transmission was 
determined in this investigation. 76% of all breast milk transmissions occurred 
during the first six months of life indicating that substantial transmission takes 
mainly part during early breastfeeding. 
Finally, this study found that HIV-1 free survival rates at two years were 
significantly lower in the breastfeeding group than in the formula one. Only 58% 
of the women who practised breastfeeding had an infant at two years, who was 
alive and HIV-1 infection free. 
COUTSOUDIS et al. [2000] did a research about feeding patterns and HIV 
transmission in Durban, South Africa. Three different types of feeding practices: 
exclusive breastfeeding, mixed breastfeeding and never breastfed were 
investigated and compared. The three feeding groups did not differ significantly 
in any other risk factors (preterm delivery, mode of delivery, duration of 
membrane rupture, maternal CD4:CD8 cell ration, CD4+ cell count or serum 
retinol level) identified to be associated with MTCT. There were no differences 
in diagnosis with mastitis or breast abscesses during follow up among 5 out of 
118 exclusive breast feeders compared with 5 out of 276 mixed breast feeders. 
Mastitis or breast abscesses were not significantly higher among mothers of 
breastfed children who acquired HIV infection. Infants who were exclusively 
breastfed had no excess risk of MTCT of HIV-1 over six months when 
compared with infants who were not breastfed at all but given formula and other 
food [COUTSOUDIS et al., 2000]. Those at the highest risk were infants fed by 
HIV positive mothers on a mixture of breast milk and other foods and liquids. 
The exact mechanism is still under debate, but it may be associated with a 
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decrease below a critical threshold of protective factors in breast milk as a result 
of the consumption of less breast milk and replacement by formula and other 
liquids and solids. The scientists concluded that contaminated fluids and food 
introduced in mixed breastfed babies damage bowel and facilitate entry into the 
tissues of the HIV contained in breast milk.  
 
An Indian study showed an increased risk of hospitalization, resulting from 
increased risk of morbidity, for formula fed Indian infants who were born to HIV 
infected mothers, compared with breast fed infants [PHADKE et al., 2003]. In 
the mentioned study all women received prenatal Zidovudine (ZDV) therapy for 
prevention of MTCT. Four infants died during the research, but it is worth to 
mention, that none of the infants was breastfed and HIV-1 PCR positive at 48 
hours or two months postpartum. The scientists concluded that the use of 
prenatal ZDV or Nevirapine can significantly reduce the risk of MTCT and that 
the risks associated with commonly utilized alternative infant feedings and not 
with exclusive breastfeeding. 
 
MTCT – the role of breast milk 
Mastitis is an inflammation of the breast tissue characterized by an elevated 
concentration of leukocytes and sodium in breast milk caused by the opening of 
the paracellular pathways between mammary cells. It can result from different 
causes, such as a local mammary inflammation in response to either 
mechanical or infectious insult, milk stasis or mammary gland involution derived 
from reduced breast milk production as seen during weaning, micronutrient 
deficiencies or systemic infection [WILLUMSEN, 2002].  
Breast milk sodium concentration is controlled around 5- 6 mmol/L, but in the 
case of mastitis it raises to 12- 16 mmol/L. Another indicator for breastfeeding 
problems and mastitis is the Na+/K+ ratio of the milk, which should be less than 
0.6. Ratios greater than 1.0 indicate severe breastfeeding problems. There is 
evidence that HIV infected cells enter breast milk via this pathways, thereby 
increasing the HIV load and the risk of MTCT [DREYFUSS and FAWZI, 2002]. 
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Infant thrush and mastitis also interrupts the mucosal barrier to transmission. In 
addition, mucosal infection with candida species results in migration to the site 
of infection of large numbers of activated CD4+ cells and macrophages, which 
are the primary target cells for HIV-1. Thrush and mastitis both result in immune 
activation. 
 
WILLUMSEN et al. [2001] found that the HIV-1 load in breast milk was below 
the level of detection (<200 copies/ml) in approximately one third of samples 
(90 participants) and was shed intermittently during the course of lactation over 
the first three months postpartum. The viral load of the breast milk was often 
below the detection limit in one breast, but could be determined in the other 
breast - no clear pattern could be observed in this investigation. 
 
In another study by WILLUMSEN et al. [2003] the associations between 
subclinical mastitis, breast milk RNA viral load and infant feeding practices 
among breastfeeding HIV positive women in South Africa were investigated. In 
this survey a significant positive association between the Na+/K+ ratio as well as 
the IL-8 plasma concentration and the milk RNA viral load was found. There 
was no interaction between feeding mode and the effect of Na+/K+ ratio on RNA 
viral load, but there was a trend for higher viral load at all times in the mothers 
of the postnatal infected group compared with the uninfected group and a 
significantly higher Na+ K+ ratio in milk after 14 weeks. These children may have 
acquired infection through breast milk in early life, but available techniques 
cannot differ between this from of MTCT and delivery-acquired infection 
[WILLUMSEN et al., 2003].  
 
MIOTTI et al. [1999] published following results of a study done in Malawi, 
where 47 of 672 breastfed infants became HIV positive: The cumulative risk of 
infection for infants continuing to breastfeed was 3.5%, at the end of five 
months, 7% at the end of 11 months, 8.9% at the end of 17 months and 10.3% 
at the end of 23 months (Fehler! Verweisquelle konnte nicht gefunden 
werden.). Still, symptomatic mothers are believed to transmit HIV more often to 
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their infants than asymptomatic women. Researchers could not find any 
connection or evidence for this assumption in the investigation. Compared to 
asymptomatic mothers, symptomatic mothers and mothers who died had a 
similar transmission rate. The finding of a higher postnatal transmission risk in 
women with lower parity was unexpected, as the women’s younger age would 
likely be accompanied by lesser virologic and immunologic compromise. 
According to KUHN et al. [1997] this may be consistent with the hypothesis, that 
mothers who are less experienced with breast feeding are more likely to have 
subclinical mastitis and thereby a higher HIV transmission rate. This could be 
confirmed by the study of MIOTTI et al. [1999], where no association between 
clinical mastitis or cracked nipples and a higher MTCT rate was found. 
 
Table 3: Risk Factors for HIV Transmission through Breastfeeding 
[Mod.: MIOTTI et al., 1999] 
 Comparison Infants 
   HIV infected No infected 
Mother’s age 
(y) 
>25 (256) <25 (413) 46 623 
Breast 
Problems 
No (354) Yes (73) 28 399 
Birth Weight 
(g) 
<2500 (111) >2500 (559) 47 623 
Parity 1-3 (478) >4 (194) 47 625 
 
 
MTCT – the role of nutrients 
SEMBA et al. [1999] found evidence, that oxidative stress and immune 
dysfunction are associated with increased risk for mastitis. Furthermore it is 
known, that micronutrient deficiencies may increase the susceptibility to mastitis 
by contributing this conditions. In a randomized dietary supplementation trial of 
pregnant women in Tanzania, not vitamin E rich sunflower oil but vitamin A rich 
red palm oil significantly reduced the risk of mastitis at three months postpartum 
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[FILTEAU, 1999]. The HIV status of the individuals was not assessed, so the 
potential beneficial effects of supplementation on HIV viral load in breast milk 
and MTCT could not be examined.  
In a view studies it has been showed, that micronutrient supplementation during 
pregnancy reduced the risk of low birth weight and preterm birth which may be 
risk factors for vertical transmission during delivery or breast feeding. In several 
studies it was reported that HIV infected women were at increased risk of 
delivering low birth weight babies, of preterm deliveries and intra uterine growth 
retardation [OSMAN et al., 2001; COLEY et al., 2001; DREYFUSS et al., 2001]. 
However, coherence between low birth weight babies of HIV infected women 
and a poor nutritional status of the mothers is still discussed controversial.  
A study carried out in South Africa did not find significant differences between 
birth weights of the babies of HIV infected and non infected women [BOBAT et 
al., 2001]. 
 
There is evidence, that MTCT in uteri or through breast feeding can be 
influenced by the epithelial integrity of the gastrointestinal mucosal lining of the 
foetus and infants. The risk can be reduced by the barrier function of the 
gastrointestinal mucosal epithelium and by the immune response in the gut. 
Vitamin A and Zn deficiencies are associated with epithelial impairment in the 
gastrointestinal tract. 
 
2.4. Selenium 
 
2.4.1. Function 
 
Se is a very important component of glutathione peroxidase (GSH-Px), which is 
a reducing equivalent of glutathione. GSH-Px catabolises the reduction of 
organic and anorganic hydroperoxides and thereby exerts antioxidant effects in 
the human organism. Due to its protective effect against autotoxic processes 
GSH- Pxs can be found in high amounts in macrophages and erythrocytes. Up 
to now 4 Se dependent GSH-Pxs, all with different specifity have been identified 
[SHIKE et al., 2006] (Fehler! Verweisquelle konnte nicht gefunden werden.). 
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Table 4: Different Types of GSH- Px 
[Mod.: SHIKE et al., 2006] 
GSH- Px 1 Most abundant member, present in all cells 
GSH- Px 2 Cellular enzyme in the gastrointestinal tract 
GSH- Px 3 Present in plasma and milk 
GSH- Px 4 Phospholipide hydro peroxide, 
Catalyzes the reduction of fatty acid hydro peroxides that are 
esterified in phospholipids 
 
 
The GSH-Pxs catabolise hydrogen peroxide and fatty acid derived 
hydroperoxides. They have generally been considered to protect cells from 
these oxidant molecules. The GSH-Pxs have regulatory roles in the cell by 
affecting the concentrations of oxidant molecules. Moreover, the GSH-Pxs have 
different localizations and substrate specificities, which could be part of a 
regulatory strategy.  
In the enzymatic neutralization of reactive oxygen species (ROS), SOD 
catabolises the transformation of a superoxide radical into H2O2. GSH-Px 
detoxifies H2O2 and lipid peroxides (ROOH) using reduced glutathione (GSH). 
This reaction prevents the formation of an extremely toxic hydroxyl radical. 
During this reaction, GSH is transformed into oxidized glutathione (GSSG) 
which is regenerated again (to GSH) via glutathione reductase (GR) in 
presence of NADPH (Figure 1). 
 
Figure 1: GSH- Px Circle 
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 H2O2 oder 
ROOH 
H2O oder 
ROH 
Glucose-6-Phosphat 
6-Phosphoglukonat GSSG 
NADP+ 
NADPH 
2 GSH 
Glutathion-Peroxidase Glutathion-Reduktase 
Glucose-6-Phosphat- 
Dehydrogenase 
 
Furthermore Se is part of some more enzymes (Fehler! Verweisquelle konnte 
nicht gefunden werden.). 
 
Table 5: Selenium dependent Enzymes 
[Mod.: ELMADFA and LEITZMANN, 2004] 
Iodithyronine 
Deiodinases 
Type 1- 3 
Catalyze the deiodination of thyroxine, 
triiodthyronine and reverse triiodthyronine and 
thereby regulate the concentration of the active 
hormone triiodthyronine  
Thioredoxin Reductase A flavin containing selenoprotein dependent on 
reduced nicotinamide adenine dinucleotide 
phosphate that reduces the internal disulfide of 
thioredoxin.  
3 isoforms: one in the cytosol, one in the 
mitochondrion and the third is expressed in the 
testis.  
Selenoprotein P An extracellular glycoprotein found in plasma and 
also associated with endothelial cells. One function 
of selenoprotein P is to supply Se to the brain to 
maintain normal neurologic function and to the testis 
for spermatogenesis.  
Selenoprotein P contains a large fraction of the 
plasma selenium. It has been associated with the 
oxidant defense properties of selenium.  
Selenoprotein W Is bound to GSH, for RedOx exchanges, 
Selenoprotein W concentration decreases in Se 
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deficiency.  
 
 
2.4.2. Deficiency 
 
Se deficiency coexists with sever protein- energy malnutrition in humans. 
Deficiency of Se leads to marked changes in many biochemical systems. It 
decreases GSH-Px activities (used as index of the human Se status) in plasma 
and liver and is very sensitive to Se supplementation. In case of Se deficiency 
the phagocytic activity is restricted and the influence for infectious diseases is 
increased.  
Se deficiency also reduces antibody production, cytokine synthesis, cell- 
mediated cytotoxicity and lymphocyte proliferation, is affecting the cytochrome 
P 450 system and responsible for the changes in thyroid hormone metabolism. 
The micronutrient deficiency in itself does not usually cause clinical symptoms 
in a free living human, but it can influence the course of various infections (e.g. 
coxsackievirus infections).  
 
2.4.3. Assessment 
 
Biochemical evaluations like measurement of selenoproteins, such as plasma 
selenoprotein P and GSH-Px, are useful in assessing the Se status in humans. 
Their assessments in blood or its fractions appear to be a satisfactory method 
to get information about the Se status in clinical practise and experimental 
investigations (Fehler! Verweisquelle konnte nicht gefunden werden.). Thus, 
adequate Se nutriture can be assumed if plasma GSH-Px activity and 
selenoprotein P concentration are normal or if plasma Se concentration is about 
1 µmol/L or greater [ELMADFA and LEITZMANN, 2004; SHIKE et al., 2006]. 
 
Table 6: Assessment of Selenium in blood fractions 
[Mod.: ELMADFA and LEITZMANN, 2004] 
Plasma/ Serum level Short term  
Acceptable Status: 7.9 µg/dl 
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Young Healthy Women: 5.3 – 7.9 µg/dl 
Pregnant/ Nursing Women: 4 - 8 µg/dl 
Blood cells Long term  
GSH-Px activity in erythrocytes and/or thrombocytes 
Germany: 11.3 – 7.5 µg/dl 
Urine Very seldom 
Germany: 1.1 – 2.3 µg/dl 
The most common functional index of Se status includes activity of GSH-Px in 
plasma, erythrocytes or whole blood. Based on data from large number studies, 
DIPLOCK [1993] concluded that blood or plasma Se correlated well with 
erythrocyte GSH-Px activity. With daily intakes up to 40 µg the enzyme activity 
reaches a plateau. Erythrocyte GSH-Px activity increases with intakes up to 60 
to 80 µg/d, while platelet GSH-Px activity only plateaus with intakes around 100 
- 110 µg/d [VAN DAEL and DEELSTRA, 1993]. 
Furthermore, Se urinary excreted as trimethylselenium can be used to assess 
the Se status of an individual.  
Assessments of Se status by calculating the dietary intake from food 
composition tables is a risky procedure because of the wide variation in the Se 
content of foods. To make accurate statements a direct chemical analysis of the 
diet would be needed. 
 
2.4.4. Source and Recommended Intake 
 
In a Se rich soil, cereals may comprise about 75% of the total Se intake, but if 
the soil is poor, they may provide less than 10% of the intake. Liver, kidney, and 
seafood tend to have the highest amounts of Se (0.4 - 1.5 mg/kg wet weight). 
Dairy products provide <0.1 to 0.3 mg/kg, and fruits and vegetables show <0.1 
mg/kg, only. 
The daily recommended intake of Se for lactating women and infants is given in 
Fehler! Verweisquelle konnte nicht gefunden werden.: 
 
Table 7: Recommended Intake of Selenium 
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[Mod.: D_A_CH, Referenzwerte für die Nährstoffzufuhr, 2001] 
Lactating women 30- 70 µg/d 
Infants 0- 4 months 
Infants 4- 12 months 
5- 15 µg/d 
7- 30 µg/d 
 
 
 
2.4.5. Selenium and HIV/ AIDS 
 
In HIV infected people, the progression to AIDS and the decline of T-helper cell 
counts, are accompanied by a parallel decrease in blood Se levels. Se 
deficiency has been found to correlate with an increase of mortality among HIV 
infected individuals, even during asymptomatic stages.  
The decrease of Se is even more important when there are opportunistic 
infections. The loss of CD4+ lymphocytes and other immune cells causes a 
progressive weakening of the immune system. Microbes that are normally kept 
in check by the immune system do have the opportunity to flourish and cause a 
disease. Opportunistic infections like cytomegalovirus disease, mycobacterium 
avium complex, tuberculosis and cancer are directly responsible for up to 90 % 
of deaths associated with HIV disease. 
 
Se supplementation is able to stimulate the proliferation of activated T-cells of 
the immune system. It elicitates an enhancement to response to antigen 
stimulation, to generate cytotoxic lymphocytes, to destroy tumor cells and to 
increased natural killer (NK) cell activity. Additionally, growth regulatory IL-2 
receptors on the surface of activated lymphocytes and NK cells become 
unregulated in case of Se supplementation. IL-2 is very important for 
lymphocytes reproduction and their differentiation into cytotoxic cells. Also a 
lower content of IgM and IgG has been discussed.  
 
HIV infection favours greater oxidative stress, which can lead to a higher viral 
replication [STEBENS, 2004]. GSH-Px and thioredoxin reductase (TRx), which 
include Se, play an important role in oxidative stress reduction (see 2.4.1) and 
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may inhibit the HI virus replication. The increase of free radicals leads to 
increased viral replication and an increase of host cell apoptosis, particularly 
CD4+ cells. SANDSTRÖM et al. [1998] showed in a well exhibited study that 
cells over expressing GSH-Px accelerated viral replication and were associated 
with cytopathogenetic effects. A progressive depletion of GSH or plasmatic 
thiols has been observed through the course of the HIV infection. The decrease 
is directly correlated with the number of CD4+ cells and inversely correlated with 
the viral load. There is a poor survival rate for HIV infected individuals with 
lower GSH levels and an improved survival rate when GSH is replenished and 
maintained [RODRIGUEZ et al., 2000]. 
In addition to these effects daily supplementation of 100 µg Se (as 
selenomethionine) for 12 months leads to a modulation of GSH-Px activity in 
HIV positive patients [DELMAS-BEAUVIEAUX et al., 2006]. In patients 
allocated to daily Se supplements, the erythrocyte GSH-Px increased from 47 to 
67 U/g Hb, while it declined from 63 to 36 U/g Hb in HIV infected patients not 
receiving supplements. Allegedly there was a decline in oxidative stress 
markers in the Se group and an increase in the non- supplemented group, while 
there was no effect of Se on CD4+ counts or the incidence of opportunistic 
infections [CONSTANS, 1999]. 
 
2.4.6. Selenium and MTCT 
 
It is very important to mention, that in a pregnant AIDS patient a low Se 
concentration can lead to a higher risk of foetal mortality and a higher risk of 
intrapartal transmission [KUPKA et al., 2005]. 
 
2.5. Zinc 
 
2.5.1. Function 
 
In general the function of Zn in human body can be categorized in a catalytic, 
structural and regulatory one. Zn is part of many different enzymes e.g. 
metalloenzymes, which are important for the RNA and protein biosynthesis and 
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performs a catalytic role in various types of enzymes (there are about 300 
enzymes, whose activity depends from Zn) [ELMADFA and LEITZMANN, 
2004].  
Cu/Zn- superoxide dismutase (SOD) is essential for the antioxidant defence 
system in humans (Fehler! Verweisquelle konnte nicht gefunden werden.). 
 
Figure 2: Cu/Zn- SOD Circle 
 
(A) Cu2+ − SOD + O2− → Cu1+ − SOD + O2 
 
(B) Cu1+ − SOD + O2− + 2H+ → Cu2+ − SOD + H2O2 
 
 
 
Besides, Zn does have a catabolic effect on the quarter structure of 
holoenzymes, which makes them more resistant for heat and pH- changes. 
 
Micronutrients are able to affect the function of the immune system and Zn is 
undoubtly playing a central role over here. Cells of the immune system do have 
a short life span, proliferate and differentiate instantly. Zn deficiency can lead 
easily to various and heavy immune dysfunctions in the humoral as well as in 
the cellular immune system (s.2.5.2). Zn is important for thymocyte 
development, T-cell function and thymic integrity. It is essential for the thymic 
functions by means of a Zn dependent thymic hormone called thymulin, which is 
indispensable for the differentiation and maturation of T cells. 
The micronutrient is also necessary for the regulation of gene expressions. 
Especially in those enzymes, which are connected to bring up nucleic acid. It is 
also part of transcription factors in form of Zn- fingers (Fehler! Verweisquelle 
konnte nicht gefunden werden.). Zn- fingers do have a definite domain, which 
interact with the DNA. This is for a specific recognition of attaching DNA- 
sequences. Zn- fingers are also essential to the viral structure, proviral DNA 
LITERATURE REVIEW 
 22 
synthesis and production of infectious viruses and are required for the activity of 
reverse transcriptase [TANCHOU et al., 1998]. 
 
Classic examples of Zn- fingers are the retinoic acid and calcitriol receptors. 
DNA arrays have recently shown that Zn deficient human monocytes and 
macrophages have gene clusters that are either positively or negatively 
responsive to Zn. This includes genes associated with apoptosis and receptor 
mediated immune regulation [SHILS et al., 2005].  
Zn does play an important role in cell proliferation and in protein biosynthesis. 
Additionally it is supposed, that Zn does also have an influence on hormone 
metabolism e.g. insulin, growth hormones and sexual hormones.  
 
 
 
Figure 3: Zn- Fingers [www.wikipedia.org, 2008] 
 
 
2.5.2. Deficiency 
 
Zn deficiency belongs to the most common malnourishments worldwide. In 
accordance with age and physiological status some population groups have 
increased daily physiological requirement for absorbed Zn. The new synthesis 
of tissue during growth, pregnancy and lactation period requires higher daily 
intakes of zinc [SHILS et al., 2005]. Therefore, infants, pregnant and lactating 
women, young children and children recovering from malnutrition belong to 
those groups with higher Zn requirements and are thus at elevated risk for Zn 
deficiency.  
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Some evidence exists for the occurrence of deficiency among each named 
group in developing countries. Conclusions can be made as to consequences of 
Zn deficiency during pregnancy on maternal, foetal and infant health.  
Zn deficiency results in a high number of adverse effects especially affecting the 
immune system (Fehler! Verweisquelle konnte nicht gefunden werden.).  
 
 
 
Table 8: Adverse effects of Zn deficiency  
[Mod.: SHILS et al., 2005] 
Immune- system dependent Other 
 General deteriorated immunity  
 Affected humeral immunity 
 Lymphopenie 
 Affected maturation and 
proliferation of T- cells 
 Thymusatrophy 
 Alleviated skinatrophy 
 Lower status of FTS (hormone 
of the thymus) 
 Stunting 
 Alleviated wound healing 
 Loss of appetite, loss of smell 
and taste 
 Complications during pregnancy 
 Disturbed metabolism of nucleic 
acids, proteins, carbohydrates, 
and fat 
 
 
Zn deficiency can be attributed to five general causes occurring either in 
isolation or combination. These are inadequate intake, increased requirements, 
malabsorption, increased losses and impaired utilization [GERSHWIN et al, 
2000]. 
 
2.5.3. Assessment 
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The efficient regulation of Zn homeostasis complicates the diagnosis in Zn 
status in humans - no accepted reliable indicators of individual Zn status do 
exist [ELMADFA and LEITZMANN, 2004]. Zn does not have a well established 
index that can be used in the clinical laboratory to evaluate the status. In 
healthy adults the normal plasma Zn concentration range varies from 12 - 18 
µM (8 - 12 µg/dl). Assessing the Zn status on the basis of the activities of Zn 
containing enzymes (including plasma alkaline phosphatase, erythrocyte Cu/Zn-
SOD and lymphocyte 5’-nucleotidase) is discussed controversial. Combinations 
of indicators may prove the value and give good information about Zn supply 
[ELMADFA and LEITZMANN, 2003] (Table 9). 
 
Table 9: Assessment of Zinc 
Plasma/ Serum level 0.6 – 1.2 mg/l 
Blood cells 4 – 7.5 mg/l 
GSH-Px activity in erythrocytes: 
1000 – 2000 U/g Hb 
Urine 0.25 – 0.85 mg/l 
 
 
2.5.4. Source and Recommended Intake 
 
The quality of dietary Zn sources depends on the amount and bioavailability of 
Zn from the foods. Organ and flesh of mammals, chicken, fish and crustaceans 
are the richest food sources and because they do not contain phytate, they are 
particularly good sources of absorbable Zn.  
Foods of vegetable origin tend to be low in Zn, except for germs of grains and 
seeds, such as nuts and legumes. Availability of Zn from those foods is reduced 
(below 20 %) by the presence of phytic acid [GIBSON and FERGUSON, 1998]. 
Mixed animal and vegetable protein diets with a “phytic acid to Zn” molar ratio 
below 15 show a moderate Zn availability, cereal or legume based diets low in 
animal protein and with a molar ratio of “phytic acid to Zn” >15 result in a low 
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availability and have been associated with a suboptimal Zn status [GIBSON and 
FERGUSON, 1998].  
Iron in pharmacological dose decrease Zn absorption, whilst Zn deficiency 
decreases iron absorption. High doses of Zn inhibit copper absorption. Alcohol 
abuse affects Zn absorption in a negative way.  
Generally the absorption of Zn adapts to physiologic needs which are 
increasing during lactation and decreasing with aging.  
Some conditions of stress, like infectious diseases, may alert absorption 
efficiency. Losses of Zn include menstruation (0.1 - 0.5 mg total) and parturition 
(100 mg/foetus, 100 mg/placenta).  
 
Lactation produces Zn losses of 2.2 mg/d at four weeks and 0.9 mg/d at 35 
weeks. Therefore the recommended daily intake of Zn is higher for lactating 
than non-lactating young women (Fehler! Verweisquelle konnte nicht 
gefunden werden.10).  
Some women do not produce milk with normal amounts of Zn (134 µg/ 100 g 
human milk), but this defect has not been found to be due to an altered 
expression of the transporter Zn-T4 in the mammary gland [SHILS et al., 2005]. 
The availability of Zn from human breast milk is much better than the availability 
from cow milk. An exclusive breastfed infant takes up to 1 mg Zn/day and so it 
is well supplied (Fehler! Verweisquelle konnte nicht gefunden werden.10). 
In formula food the concentration of Zn is higher, but breast milk includes a 
ligand, which provides an ideal uptake of Zn by the infant. 
 
Table 10:  Recommended Intake of Zinc 
[Mod.: D_A_CH, Referenzwerte für die Nährstoffzufuhr, 2001] 
Lactating women 11 mg/d 
Infants 0- 4 months 
Infants 4- 12 months 
1 mg/d 
2 mg/d 
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During lactation the requirements for Zn are quantitatively greater than those 
during pregnancy. In the early weeks postpartum excretion in the milk is ~30 - 
40 µmol Zn/d; this declines to ~15 µmol Zn by two to three months postpartum 
[KREBS, 1998]. As shown in Fehler! Verweisquelle konnte nicht gefunden 
werden. lactating women do have a higher recommended intake than non 
lactating women.  
 
 
 
Solid symbols = lactating women 
Open Symbols = non lactating women 
Figure 4: Comparison of dietary Zn intakes for lactating and non lactating 
women in the United States and in developing countries [Mod.: KREBS, 1998] 
 
 
Numerous cross- sectional and limited longitudinal studies showed no 
consistent correlation between maternal dietary Zn intakes and milk Zn 
concentrations when maternal intakes are relatively high. Data on milk Zn 
concentrations from women in developing countries were obtained primarily by 
using cross- sectional design methods and often with wide ranges of time over 
which sampling had been undertaken. Data from several developing countries 
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and longitudinal data from well- nourished US women are compared in Fehler! 
Verweisquelle konnte nicht gefunden werden.. 
 
 
 
Connected symbols represent longitudinal  
or semi longitudinal data. 
Figure 5: Comparison of milk Zn concentrations from lactating US women 
and women in developing countries [Mod.: KREBS, 1998] 
 
 
Although the outcome of various studies dealing with the relationship between 
maternal Zn status and milk Zn concentration is inhomogeneous, the majority of 
preceded investigations support the hypothesis that low dietary Zn intake is 
associated with lower milk Zn concentrations. 
 
2.5.5. Zinc and HIV/ AIDS 
 
Zinc plays an important role in HIV infection. Its concentration in the human 
body can influence the transcription of numerous genes implicated in the 
immune system. HIV infected people are very often delicate to Zn deficiency 
because of malabsorption, loss of nutrient intake or diarrhoea. Patients with 
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AIDS exhibit clinical symptoms similar to those associated with Zn deficiency, 
including immune deficiencies, impaired taste and appetite, decreased food 
intake, gastro- intestinal malfunction with diarrhoea, alopecia, epithelial lesions 
and hypogonadism.  
30 to 50 % of adult HIV infected patients in developed and nearly 90 % in 
developing countries suffer from diarrhoea, regularly. The high incidence of 
diarrhoea among HIV patients in developing countries may not only be 
attributable to the higher exposure to pathogens due to the lack of sanitary 
facilities and clean water, but also to a cereal based diet with a lower amount of 
absorbable Zn.  
In Descriptive and analytic epidemiologic study designs have been used to 
examine the role of Zn status in HIV/ AIDS in humans. Low plasma Zn was 
observed in up to 96 % of AIDS/ AIDS related complex patients [BEACH et al., 
1992]. BODGEN et al. [2000] and MOCCHEGIANI et al. [1999] reported of a 
significant correlation between plasma Zn levels and immune parameters such 
as CD4+ T- cell counts and HIV RNA levels when data from HIV positive 
subjects were evaluated cross sectional. 
 
Zambia, the effects of Zn, Se, and vitamins A, C, E on health parameters in HIV 
patients were assessed in a randomized, placebo–controlled trial among 106 
subjects with persistent diarrhoea [KELLY and MUSONDA et al., 1999]. The 
findings of this study indicated no effect of the micronutrient supplement 
containing 200 mg of Zn given daily for 2 weeks (in total the patients were 
observed for 12 weeks) on diarrhoea, morbidity and mortality.  
LAI et al. [2001] found a connection between a low serum Zn level and the 
progression of clinical symptoms and an increased mortality among HIV 
patients. Further clinical trials investigating the effect of supplemented Zn on the 
health status of HIV patients also noticed a decreased number of opportunistic 
infections, especially in pnemocystis carinii and candida infections 
[MOCCHEGIANI et al., 2000].  
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In many different tissues, Zn constitutes are part of the defence system against 
oxidative stress because it binds to thiol groups and prevents their oxidation. Zn 
also induces the synthesis of metallothioneins, which are important ROS 
scavengers in human body.  
Cu/Zn-SOD is essential for the antioxidant defence system. Zn deficiency in 
HIV-1 infection may compromise the production of Cu/Zn-SOD and adversely 
affect the antioxidant response of the overproduction of free radicals and lipid 
peroxides observed in the early disease.  
In vitro Cu/Zn-SOD has been demonstrated to reduce HIV-1 replication 
whereas oxidative stress stimulates the replication of HIV-1 and increases the 
individual’s viral load [FAVIER et al., 1994]. However, it should be noted that the 
HI virus needs Zn for its replication and therefore a long term supplementation 
can cause negative effects (Zn enhances enzymatic activity of viral integrase 
and its zinc fingers) [LEE et al., 1997].  
The main reason for not suggesting Zn supplementation is the discovery that 
HIV- Tat protein and HIV nucleocapsid protein NCp7 are strongly Zn dependent 
with high binding affinity and both proteins are relevant for HIV replication 
[MELLY et al., 1996]. Thus, major Zn bioavailability by supplementation with Zn 
might induce a major activation of Tat and NCp7 proteins resulting in 
consequent quick viral HIV replication and rapid HIV progression.  
 
Zn metabolism is also altered in the late stages of AIDS. Some articles have 
reported a beneficial effect of supplementation with Zn on the recovery of 
immune efficiency in stage IV of HIV infection [ZAZZO et al., 1989]. Most of the 
studies have been carried out in small cohorts of concerned individuals; they 
are suggestive to give a dominant role to Zn in HIV infection to thwart the 
appearance of opportunistic infections [ISA et al., 1992; BAUM et al., 1995].  
HIV-1 infected individuals are particularly susceptible to Zn deficiency, but on 
the other hand, excessive Zn may stimulate HIV-1. 
 
2.5.6. Zinc and MTCT 
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Zn deficiency may have detrimental effects on important predictors of vertical 
transmission, such as clinical, immunological or viral stage of HIV among 
pregnant and lactating women. Zn may influence the maintenance of the child’s 
membrane integrity, which could lower a women’s risk of transmitting the virus 
[O’DELL, 2000]. By contributing to intestinal mucosal integrity and natural 
immunity, an adequate maternal Zn status may protect the breastfed child from 
contracting the virus from the mother. Additionally, Zn may prevent transmission 
by decreasing the risk for prematurity and low birth weight, which is for sure an 
intermediate risk factor for MTCT.  
 
2.6 Situation in Kenya 
 
Kenya has an estimated population of 34 million people - about 58.2% of them 
live with less than US$ 2 a day. Although Kenya has been demonstrated a clear 
trend of decreasing HIV prevalence over the past several years, there are still 
26% of the population who are living with HIV/ AIDS. During the last three 
years, critical HIV services have been scaled up and as a result general 
awareness and knowledge of HIV transmission are nearly universal. The 
downward trend was especially profound in the urban sites of Busia, Meru, 
Nakuru and Thika, where the prevalence declined from 28% in 1999 to 9% in 
2003 among 15-49 year old women attending antenatal clinics [HALLETT, 
2006]. 
 
Up to 40 % of pregnant women attending antenatal care clinics in 2004 benefit 
from prevention of MTCT services. In a study by KIARIE et al. [2004] carried out 
in the Kenyatta National Hospital in Nairobi the feeding practice of HIV positive 
women was determined. 79 % of HIV-1 infected women were practicing 
exclusive replacement feeding or exclusive breastfeeding at the first week. 
Many of the exclusive breastfeeding women started mixed feeding afterwards. 
Exclusive breastfeeding was associated with younger age and better knowledge 
about prevention of MTCT. This led to the conclusion that younger women may 
be more open receiving education and advice from clinical staff [KIARIE et al., 
2004].
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3. Research Methodology 
 
3.1. Study Design and Data Collection 
 
The data collecting took place in the Provincial General Hospital, Nakuru, 
Kenya. Over a period of three weeks 81 lactating women (between 16 and 38 
years old) were interviewed face- to- face by trained, Kiswahili speaking staff 
about their sociodemographic status, medical condition and eating habits. For 
more detailed information about their eating habits a 24- Hour Recall was used. 
Medical staff took 5 ml venous blood from each respondent for the 
determination of the Zn and Se status in the laboratory. The blood samples 
were transferred into heparin coated tubes.  
 
A total of 79 subjects took part in this study. 40.5% (n= 32) of all recruited 
women were HIV positive and 59.5% (n= 47) were HIV negative (Fehler! 
Verweisquelle konnte nicht gefunden werden.). 
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Figure 6: Respondents (total=79; HIV+= 32; HIV-: 47) and their HIV Status 
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All the infected respondents were asymptomatic at the time of data collecting. 
The negative group acted as control. The respondents had to prove their HIV 
status with the Antenatal Cards from the Ministry of Health of Kenya. Infant HIV 
status could not be determined under the age of 18 months, because the 
available tests could only determine the status onwards this age. The children 
had to have a Child Health Card from the Ministry of Kenya (Kenya Expanded 
Programme on Immunization). 
 
Pilot testing of the questionnaire was done at a community eastern of Nakuru, 
where women had similar characteristics as those attending the Provincial 
General Hospital.  
 
The study was approved by the Ministry of Science and Technology, Kenya, the 
Ethics Committee of the Nakuru General Hospital, Kenya and the Ethics 
Committee of the Medical University of Vienna and the Vienna General 
Hospital- AKH, Austria. 
 
3.2. Anthropometry 
 
The mothers weight was measured with a Camry scale (0 kg - 120 kg) and their 
lengths were taken with a stadiometer (0 cm - 207 cm). The women wore light 
clothes. The lengths was taken without shoes and the women were asked to 
stand feet facing the front, shoulders and heels touching the back of the 
stadiometer bar (Fehler! Verweisquelle konnte nicht gefunden werden.).  
 
For calculating the mothers Body Mass Index (BMI) the following formula was 
used: 
 
BMI [kg/m2] = weight (kg) / height 2 (m2) 
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The body weights of the subjects were classified in under-, normal, overweight 
and obesity (Fehler! Verweisquelle konnte nicht gefunden werden.11).  
 
Table 11: BMI classification 
<18.5 
18.5-24 
24-30 
>30 
Underweight 
Normal Weight 
Overweight 
Obesity 
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 Respondent 
Number 
Age  
(years) 
Weight  
(kg) 
Height 
(cm) 
BMI 
(kg/m2) 
Total 79 27±5 59±8 159±6 23±3 
HIV+ 32 28±6 56±8 159±7 22±2 
HIV- 47 26±5 60±9 159±9 24±3 
Figure 7: Characteristics of the Respondents 
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The infants and children’s weight was measured with a Salter England scale 
(Model 2356S; 0 kg - 25 kg) or a Seca 725 1021009 (0.5 kg- 16 kg) and their 
lengths was measured with a Shorr Board (0 cm- 130 cm). They wore light 
clothes or a light blanket. For lengths measurement they wore no socks and 
shoes. 
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 Age (months) Weight (kg) Height (cm) 
Total 10±9 5.2±1.6 57.5±8.2 
HIV+ 
mothers 
9±8 5±1.8 55.3±9.3 
HIV- 
mothers 
11±9 5.3±1.4 58±7.5 
Figure 8: Infants (n=79) characteristic 
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3.4. Analysis of Selenium and Zinc Status  
 
3.4.1. Blood Preparation 
 
The venous blood samples were stored cool and transported to the 
Biochemistry Laboratory at Egerton University within four hours after being 
taken. The samples were transferred into Pyrex centrifugal tubes and 
centrifugated for 10 minutes at 3000 RPM in a bench top centrifuge (Model: 
Hettich EBA 3S). Afterwards the plasma was taken off and the red blood cells 
were left in the tubes. The erythrocytes were washed for three times with an 
isotonic phosphorus buffer. Afterwards the erythrocyte suspensions were frozen 
(-20°C) in 500 µl Eppendorff tubes. 
 
3.4.2. Analysis of Glutathione Peroxidase (GSH-Px) EC 1.11.1.9 Activity in 
Erythrocytes 
 
Method 
In a first reaction of this method [BEUTLER, 1984] glutathione peroxidase 
(GSH-Px) catalyzes with hydroperoxides the oxidation of reduced (GSH) to 
oxidized glutathione (GSSG). In a second reaction the GSSG changes into 
GSH in the presence of NADPH2 and glutathione reductase (GR). The decrease 
of NADPH2 is proportional to GSH-Px activity and can be measured 
photometrical. 
 
                                                   GSH-Px 
               2 GSH + ROOH                                   GSSG + ROH + H2O 
                                                       GR 
             GSSG + NADPH2                                   2 GSH + NADP
+ 
 
Material and Equipment 
 
 
Reagents:  
Glutathione (reduced) Roche                                 Nr.127736 
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Glutathione Reductase (GR) fr. yeast Roche                                 Nr.105678 
NADPH Tetrasodiumsalt Roche                                 Nr.107824 
t-Butylhydroperoxide, 70% (BHP) Fluka                                  Nr.199955 
Tris(hydroxymethyl)-aminomethan- 
Hydrochloride 
Fluka                                    Nr.93350 
Sodium-EDTA Riedel de Haën                    Nr.27285 
Potassiumhexacyanoferrat Merck                                     Nr.4973 
Potassiumcyanid Aldrich                               Nr.20781-0 
aqua dest.  
Solutions:  
GSH-Solution [1 M]: 61.46 mg Glutathione in 2 ml aqua dest. 
GR-Solution [10 U/ml]: 50 µl GR solution in 2950 µl aqua dest. 
NADPH-Solution [2 mM]: 3.48 g NADPH in 2 ml aqua dest. 
BHP-Solution [7 mM]: 20 µl t-BHP in 20 ml aqua dest. 
Tris-Buffer [1 M]: 15,76 g Tris-HCl + 186 g Sodium-EDTA in 100 ml aqua 
dest., pH 8.0  
Haemoglobine Reagent: 198 mg Potassiumhexacyanoferrat + 49 mg 
Potassiumcyanid in 1l aqua dest.  
Equipment: 
 
 
pH-Meter (Model: EZDO, PL- 500) 
Water bath (Model: ub5- nüve) 
Scale (Model: Citizen, CY220; 0.01 g- 220 g) 
UV/ VIS Photometer (Model: CE 2021 Cecil, 2000 Series) 
 
Analysis 
 
For the analysis of GSH-Px activity 100 µl of an erythrocyte suspension are 
haemolyzed by adding 900 µl aqua dest. Following pipette pattern was used:  
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Reagents Blank [µl] Sample [µl] 
aqua dest.  670 660 
Tris-Buffer  100 100 
GSH 20 20 
GR 100 100 
NADPH  100 100 
Haemolysat  - 10 
mix well and incubate 10 Minutes at 37°C  
t-BHP  10 10 
 
After adding t-BHP the decrease of the extinction (340 nm) was measured over 
a time period of 90 seconds.  
The haemoglobin concentration was determined photometrical (546 nm) after 
mixing 100 µl erythrocyte suspension and 5 ml haemoglobin reagent. 
Evaluation 
 
The calculation of the GSH-PX activity is based on the Lambert-Beer´s Law: 
 
 
E = ε * c * d 
 
E = extinction, ε = molar extinction coefficient [1mol
-1
.cm
-1
.l], c = concentration/ activity, d = width of the cuvette [cm] =1 
 
 
Following formula was used for calculating the activity of the erythrocyte GSH-
Px: 
 
 
Activity of GSH-Px:                A = ΔE * Vc / (6.22 * VH) 
 
A = activity of GSH-Px, ΔE = decrease of the extinction/min, Vc = total volume, VH = volume of the haemolysate, 6,22 = 
molar extinction coefficient [lmmol
-1
cm
-1
] of NADPH at 340 nm 
 
Activity of GSH-Px:             A * 100/Hb [g/dl] = U/g Hb 
 
A = activity of GSH-Px, Hb = concentration of haemoglobin, U = units  
 
The coefficient of variation of this method was 1.86 %. 
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3.2.1. Analysis of the Superoxide Dismutase Activity (SOD) EC 1.15.11 in 
Erythrocytes 
 
Method 
The activity of SOD was measured using the method of MARKLUND and 
MARKLUND [1974], modified by BEUTLER [1984]. SOD is able to stop the 
autoxidation of pyrogallol. Pyrogallol autoxidates in watery solution very fast and 
gives a yellowish colour which concentration is measured photometrical. 
 
                                                         SOD 
                              2 O2
-  + 2 H                         O2 + H2O2 
 
Material and Equipment 
 
Reagents:  
Pyrogallol Riedel de Haën                    Nr.16040 
Ethanol p.a. Riedel de Haën                    Nr.32221 
Methanol p.a. Merck                        Nr.106009.2500 
Chloroform Riedel de Haën                    Nr.32286 
HCl 37% Riedel de Haën                    Nr.30721 
Tris(hydroxymethyl)-aminomethan- 
hydrochlorid 
Fluka                                    Nr.93350 
Sodium-EDTA Riedel de Haën                    Nr.27285 
Potassiumhexacyanoferrat Merck                                     Nr.4973 
Potassiumcyanid Aldrich                               Nr.20781-0 
Solutions:  
Pyrogallol-Solution: 126.11 mg Pyrogallol + 82 µl HCl in 100 ml aqua dest. 
Tris-Buffer [1 M]: 15.76 g Tris-HCl + 186 g Sodium-EDTA in 100 ml aqua 
dest.; pH 8.0  
Haemoglobin Reagent: 198 mg Potassiumhexacyanoferrat + 49 mg 
Potassiumcyanid in 1l aqua dest. 
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Equipment: 
 
pH-Meter (Model: EZDO, PL- 500) 
Centrifuge, 3000 RPM (Model: Hettich EBA 3S) 
Water bath (Model: ub5- nüve) 
Scale (Model: Citizen, CY220; 0.01 g- 220 g) 
UV/ VIS Photometer (Model: CE 2021 Cecil, 2000 Series) 
 
Analysis 
 
300 µl of the erythrocyte suspension are haemolyzed by adding 450 µl aqua 
dest.. 500 µl of this haemolysate are mixed with 3.5 ml aqua dest., 1 ml ethanol 
and 600 µl chloroform, vortexed for 60 seconds and centrifuged for 2 minutes 
(3000 U/min). The upper phase of the conditioned sample is used for this 
pipette pattern:  
 
Reagent BL [µl] A1 [µl] A2 [µl] A3 [µl] A4 [µl] A5 [µl] 
Tris-Buffer 100 100 100 100 100 100 
aqua dest. 880 840 820 780 730 680 
Sample 0 40 60 100 150 200 
mix and incubate 10 minutes at 25 °C  
Pyrogallol- 
Solution 
20 20 20 20 20 20 
BL…blank; A…sample 
 
After addition of pyrogallol the extinction (320 nm) is measured over a time 
period of 3 minutes. 
Determination of haemoglobin s. 0. 
 
Evaluation 
 
ΔE/min is calculated for all six concentration steps of each sample using a 
linear regression. 
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The concentration of the sample (x) at the 50% inhibition of the autoxidation of 
pyrogallol is calculated by using this formula: 
 
y = k * x + d                                       x = (y – d)/k 
 
x = concentration of the sample at 50% inhibition of the pyrogallol autoxidation 
y = (ΔE/min)/2 of the sample blank 
k = gradient of the curve  
d = point of intersection of the curve with the y-axis  
 
The activity of the erythrocyte SOD has been calculated as followed: 
A = GV/(PV * x) 
A = enzyme activity, GV = total volume = 5.6 ml, PV = volume of the sample = 0.5 ml, x = concentration of the sample at 
50% inhibition of pyrogallol autoxidation 
 
Activity of SOD:             A * 100/Hb [g/dl] = U/g Hb 
 
A = activity of SOD, Hb = concentration of haemoglobin, U = Units 
 
The coefficient of variation of this method was 1.9%. 
 
3.5. Evaluation and Statistical Analysis 
 
Statistical Package for Social Sciences (SPSS) for Windows (Version 15.0) was 
used for all statistical analysis. Distribution of the data was tested by 
implementing the Kolmogorov-Smirnov Test. Summary statistics (frequencies) 
were used to describe the data and trends, independent sample t-tests were 
used to describe differences between the HIV positive and HIV negative women 
for the various factors. Partial and bivariate correlations were used to describe 
coherences between different factors.  
For assessing the mothers’ nutrient intake, 24-Hour Recalls were evaluated by 
the Nutrisurvey program Kenya (www.Nutrisurvey.de ). 
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4. Results and Discussion 
 
4.1. Sociodemographic data 
 
Demographic Data 
Demographic data showed that 65% of all women participating in this study 
lived out of town, 10% in an urban area, 10% in a peri- urban area and 15% in a 
rural area of Nakuru.  
Within the HIV positive women 37% lived out of town and 3% lived in urban 
areas. 16% lived in peri- urban and only 9% in rural areas.  
In the HIV negative group 65% lived out of town, 10% lived in urban areas, 15% 
in rural areas, and 10% in peri- urban areas (Fehler! Verweisquelle konnte 
nicht gefunden werden. 9). 
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Figure 9: Origin of the Respondents 
 
 
Refuge/Migration 
35% (HIV+: 36%, HIV-: 64%) of the study participants had to leave their homes 
during the post election violence in January and February 2008. This fact was 
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also recorded during this study because living in a place of refuge is known to 
have a great influence on the nutritional status of humans. There was no 
statistical significance between the infected and uninfected women concerning 
this situation. 
 
Marital Status and Age 
More than three quarter (78%) of all respondents were married, 14% were 
single living mothers, 4% lived divorced or separated from their husbands and 
another 4% were widowed.  
In the HIV positive group 56% of the women were married, 26% lived in single 
households, 9% were separated or divorced from their partners and 9% were 
widowed.  
The marital status of HIV negative women was quite different from that of HIV 
positive participants. In contrast to the HIV positive group, 94% of all HIV 
negative respondents were married and just 6% were single living mothers 
(Figure 10).  
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Figure 10: Marital Status of the Respondents 
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There are big differences in the marital status of HIV positive and HIV negative 
women, but there is no statistical significance (p< 0.106).  
 
The evaluation of these sociodemographic parameters shows, that more than 
half of the investigated women were living out of town, were middle aged (total: 
27±5 y; HIV+: 28±6 y; HIV-: 26±5 y) and married (Figure 11). 
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Figure 11: Age (years) of the Respondents 
 
 
Education 
96% (HIV+: 38%; HIV-: 62%) of all investigated women participating in the 
study had at least basic education (primary school), 47% (HIV+: 22%; HIV-: 
78%) had a higher (secondary or tertiary) graduation and only 4% (HIV+: 4%; 
HIV-: 0%) did not have any school leaving certificate. 
This means that 49% of all interviewed women had a school leaving certificate 
of primary school, 37% of secondary school, 10% had a tertiary education 
(university degree) and only 4% had not got any education. 
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However, data pointed out that there was a big gap between the HIV positive 
and HIV negative group in terms of education. HIV negative women had 
significant (p< 0.05) higher school leaving certificates than HIV positive women.  
When the education factor was broken down according to HIV status following 
outcome could be observed:  
In the positive group 9% had no education at all, 66% attended to primary 
school, 16% to secondary school and 9% to tertiary school. Among the HIV 
negative participants the majority had a graduation of secondary school (51%). 
38% had attended primary school and even 11% had a tertiary education 
(Figure 12).  
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Figure 12: Educational Status of the Respondents (*: HIV+< HIV-; p>0.05) 
 
 
Statements and Discussion: Sociodemographic Data  
The impact of demographic data is very important for an adequate food supply. 
Women, who are married, do have more money to buy food and have more 
time to farm their fields, than women who are single living, divorced or widowed 
and have to do both, earning money and farming.  
* 
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In a large epidemiologic study DARMON and DREWNOWSKI [2008] showed 
that diet quality followed a socioeconomic gradient. Higher-quality diets were 
associated with greater affluence energy-dense diets that are nutrient-poor 
were preferentially consumed by persons of lower socioeconomic status and of 
more limited economic means. They demonstrated that whole grains, lean 
meats, fish, low-fat dairy products, fresh vegetables and fruit were more likely to 
be consumed by groups of higher socioeconomic status. In contrast, the 
consumption of refined grains and added fats had been associated with lower 
socioeconomic status. Although micronutrient intake and diet quality are 
affected by education and origin, little evidence indicated that mentioned factors 
affected either total energy intakes or the macronutrient composition of the diet. 
 
Also education is a very important factor influencing the nutritional status of 
humans. Well educated women do have a better knowledge about adequate 
nutritional supply, HIV/ AIDS and its prevention of transmission. In order to 
inform about general health, MTCT, HIV/ AIDS or nutrition it is very useful, if the 
women are able to read and write. So, the educational standard of a pregnant/ 
lactating woman is very important for the implementation of possible 
interventions, training programs and further care. 
 
HIV Status 
Among both, urban and rural residents the seroprevalence was found to be 
rising significantly (p<0.01) with increasing educational attainment. Further, it 
also shows the likelihood of being infected is slightly higher among unmarried 
women than married. Within the HIV positive group 26% were single living 
mothers whereas in the HIV negative group only 6% were single living women. 
FYLKESNES K et al. [1997] confirmed this result in a Zambian study 
investigating this impact on the HIV status of childbearing women.  
 
Infants and HIV status 
Within the HIV positive group 28% of the children were known to be HIV 
positive. Because of the difficulty of HIV determination in infants, it could be 
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possible, that the named number is higher and the Number of HIV negative 
infants is lower than 72%. 
44% of the HIV positive mothers within the HIV positive infant group chose the 
exclusive breastfeeding option and 56% the mixed feeding option.  
 
State of Health 
The HIV respondents were asked to talk about their complaints and pains like 
headache, dizziness and tiredness (Table 12). In total 39% (HIV+: 26%; HIV-
:74%) of the study participants recorded to feel free of pain, more than a quarter 
(27%; HIV+: 33%; HIV-: 67%) of all respondents complained about one 
disease, 16% (HIV+:61%; HIV-: 39%) did have two, 10% (HIV+: 75%;HIV-: 
25%) three and 4% (HIV+: 67%; HIV-: 33%) did have four illnesses. Only 3% 
(HIV+: 50%; HIV-:50 %) complained about five and 1% (HIV+: 0%; HIV-: 1%) 
about more than five health problems (Figure 13). 
 
Table 12: Frequency of Complaints 
 Total (%) HIV+ (%) HIV- (%) 
Tiredness 20 44 9 
Rash 5 9 2 
Dizziness 13 9 15 
Nausea 10 19 4 
Fever 5 3 6 
Diarrhoea 2 3 2 
Vomiting 2 6 0 
Swelling 2 3 2 
Weakness 13 22 6 
Allergy 11 9 13 
Cold 24 19 28 
Other 17 22 15 
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If HIV positive and HIV negative women were broken down to separate groups, 
a quarter (25%) of all HIV positive subjects did not have any pain. 22% did have 
one, 25% two, 19% three, 6% more than and 3% recorded to have more than 
five complaints. Tiredness (44%), weakness (22%) and colds (19%) were the 
most common illnesses within the HIV positive group. 
Among the HIV negative group almost half (49%) of the subjects were free of 
complaints, 30% of these participants were affected by one sickness, 11% 
complained about two, 4% about three, 2% about four and 4% about five or 
over five health problems. The most common health problems within the HIV 
negative group were coughs and sneezes (27.7%).  
Compared to the HIV negative group, the incidence of health problems like 
nausea, tiredness or fever etc. was significantly (p< 0.05) higher HIV positive 
study participants.  
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Figure 13: Respondents State of Health (*: HIV+ < HIV-; p<0.05) 
 
 
Further, HIV positive women recorded significantly (p<0.05) more often 
problems with their breast health and with breast feeding than HIV negative 
  * 
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women however, no significant correlations between the frequency of breast 
problems, the problems of breast feeding and their HIV status could be found.  
 
Offspring 
The results of this study showed that 59% of all participating women had one to 
two children, 28% three to four, 10% five to six children and 3% had seven to 
nine children (Fehler! Verweisquelle konnte nicht gefunden werden.14). 
 
59
28
10
3
41
34
22
3
72
23
3 2
0
10
20
30
40
50
60
70
80
1 - 2 3 - 4 5 - 6 7 - 9
F
re
q
u
e
n
c
y
 (
%
)
Total HIV+ HIV-
 
Figure 14: Number of born Children 
 
 
The results showed that HIV infected women had slightly but not significant 
more children than HIV uninfected women (HIV+: 3- 4 children = 34%; HIV-: 1- 
2 children = 72%). 
 
4.2. Anthropometric and Nutritional Data 
 
4.2.1. Anthropometric Data 
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The average BMI of all recruited women was 23.2±3 kg/m2 (min.: 18.1 kg/m2; 
max.: 36.6 kg/m2). In the HIV positive group the mean BMI was calculated at 
22±2 kg/m2. The minimum BMI in the HIV positive group was 18.7 kg/m2 and 
the highest BMI at 28.3 kg/m2. In the HIV negative group the mean BMI was 
calculated at 24±3 kg/m2, the lowest BMI at 18.1 kg/m2 and the highest at 36.6 
kg/m2 (Figure 15).  
 
3
78
15
40
96
4 04
68
21
7
0
20
40
60
80
100
120
< 18.5 (kg/m2) 18.5 - 24 (kg/m2) 24 - 30 (kg/m2) > 30 (kg/m2)
F
re
q
u
e
n
c
y
 (
%
)
Total HIV+ HIV-
 
Figure 15: BMI (kg/m2) of the Respondents 
 
 
Among the HIV positive women the mean BMI was slightly lower (22.3±2.1 kg/ 
m2) than the mean BMI (23.7±3.5 kg/ m2) of the HIV negative control group. 
There was a statistical significance between the infected and uninfected group 
(p< 0.05; CI 95%). 
 
A differentiation of the BMIs in under-, normal-, overweight and obesity 
indicated following:  
13% (HIV+: 0%; HIV-: 13%) of all recruited women were underweight (had a 
BMI lower than 18.5 kg/m2), 78% (HIV+: 48%; HIV-: 52%) were normal weight 
with a BMI between 18.5 kg/m2 and 24 kg/m2. 15% (HIV+: 17%; HIV-: 83%) 
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were overweight and had a BMI between 24 kg/m2 and 30 kg/m2 and 4% of the 
participants (HIV+: 0%; HIV-: 4%) were obese with a BMI over 30 kg/m2.  
Within the HIV positive group women were either in the normal weight group 
(96%) or in the overweight group (4%) – none of the subjects could be classified 
as underweight or obese.  
68% of the HIV negative women were in the normal weight group, 21% in the 
overweight group, 7% were obese and 4% were underweight. 
 
4.1.1. Nutritional Data 
 
24- Hour Recalls 
For calculating the nutrients intake the 24-h-Recall method was used. This 
method reflects just an impression of the nutritional intake of an average day – 
therefore, the results have to be interpreted with caution. Several factors have 
been suggested to underlie the problem of inaccurate reports, for example: 
psychosocial, behavioural and cultural factors, memory disturbance and wrong 
reporting of food portions. MENNEN et al. [2000] assumed that people from 
rural Cameroon know better than urban occupants, what they ate, since the 
food diversity may be lower and most of them are farmers, growing their own 
food and thus have less chance of underreporting their energy intake by lack of 
memory.  
 
Energy  
Within the respondent group the mean energy intake per day was 2020±609 
kcal (min.: 175 kcal; max.: 2897 kcal). The average energy intake in the HIV 
positive group was 966±496 kcal, but ranged from 175 kcal to 2020 kcal. The 
mean energy intake within the seronegative control group was 1363±627 kcal, 
the lowest daily intake among these subjects was 534 kcal and the highest 
2897 kcal (Table 12). The statistical analysis indicated a significant (p<0.05) 
difference of the total energy intake between the HIV positive and HIV negative 
group. 
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According to the Kenyan Ministry of Health [MINISTRY OF HEALTH, KENYA, 
2007] the energy intake of an asymptomatic HIV positive, lactating women 
should be 2850 kcal/d and for HIV negative, lactating mothers 2640 kcal/d. The 
evaluation of the data gained in this study clearly showed a great discrepancy 
(in both, the HIV positive and negative group) between the recommended and 
the indeed daily energy intake of Kenyan lactating women. 
 
Table 13:  Macronutrient intake assessed by a 24-h-Recalls 
Nutrient Total 
(mean±sd) 
HIV+ 
(mean±sd) 
HIV- 
(mean±sd) 
Energy (kcal) 2020 ± 609 966 ± 496* 1363 ± 627 
Protein (g) 47 ± 33 33 ± 9 55 ± 37 
Fat (g) 33 ± 30 24 ± 15 39 ± 33 
Carbohydrates (g) 176 ± 80 65 ± 81 190 ± 77 
Fibre (g) 22 ± 21 19 ± 13 24 ± 11 
Water (g) 1571 ± 691 1141 ± 464 1826 ± 679 
*: HIV+ < HIV-; p<0.05 
 
 
Protein 
The daily recommended intake of protein for lactating women is 63 g/day [D- A- 
CH; 2001]. Within the total group investigated in this study the average protein 
intake was 47±33 g/d (min.:6 g/d; max.: 181 g/d) (Tab. 12) or 16±7.4 E% (Fig. 
15). In the HIV positive group the intake was 33±9 g/d (min.: 6 g/d; max.: 46 
g/d) - so 15±9 E% of the daily energy intake was derived from protein. The HIV 
negative group had a protein intake of 55±37 g/d (min: 14 g/d; max.: 181 g/d) 
resulting in a total of 17±7 E%.  
The results of this study showed that the HIV negative group had a (not 
significant) better protein supply than the HIV positive group. However, the 
participants of both groups had an average protein intake below the 
recommended level.  
 
Meat and egg consumption 
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Meat was consumed by 63% (HIV+: 29%; HIV-: 71%) of all investigated 
subjects once a week. 28% (HIV+: 68%; HIV-: 32%) of all women ate meat 
once a month, 8% (HIV+: 34%; HIV-: 66%) every day and 1% (HIV+:0%; HIV-: 
1%) never had meat.  
The meat consumption within the HIV positive and HIV negative group was 
quite different, but no statistical significant differences could be found. In the 
HIV positive group 48% of the women ate meat at least once a month, 45% ate 
meat once a week and 7% had meat every day.  
Within the HIV negative control group almost three quarter (74%) ate meat once 
a week, 15% ate meat once a month, 9% had it every day and 2% never ate 
meat at all, because of the cost (Figure 16). 
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Figure 16: Frequency of Meat Consumption  
 
 
In the total group egg consumption could be categorized as followed: 55% of all 
women (HIV+: 36%, HIV-: 64%) stated to eat eggs weekly, 18% (HIV+: 62%, 
HIV-: 38%) monthly, 6% (HIV+: 25%, HIV-: 75%) daily, 1% (HIV+: 25%, HIV-: 
75%) once a year and 20% (HIV+: 44%, HIV-: 56%) of all respondents never 
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eat eggs. In both, the HIV positive and the HIV negative group this pattern was 
quite comparable and no significant differences were observed.  
 
Fat 
In lactating women the fat intake should be 30-35% percent of the daily energy 
intake [D- A- CH; 2001]. Within the total group of this study the daily fat intake 
was 33±30 g/d (Table 12) or 21±9.5 E% (Figure 17), ranging from 2- 151 g/d 
and 5-53 E%, respectively.  
Within the HIV positive group the fat intake was 24±15 g/d or 19±9 E%. In the 
HIV negative group the mean fat consumption per day was 39±33 g/d (min.: 4 
g/d; max.: 151 g/d) or 20±10 E%. 
 
Carbohydrates 
The daily recommended intake of carbohydrates for lactating women is set at 
50 E% [D- A- CH, 2000].  
The intake of carbohydrates observed in this study was quite high (Table 12) – 
on average 176±80 g/day, resulting in a total of 63±14 E% of daily energy 
intake. In the HIV positive group the mean carbohydrate intake was 65±81 
g/day or 66±15 E%, respectively. Especially in the HIV negative respondent 
group the average intake (190±77 g/day or 63±13 E%) of carbohydrates was 
remarkable high and well above the recommendation of 50 E%.  
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 Protein  
(E%) 
Fat  
(E%) 
Carbohydrates 
(E%) 
Total 16±7.4 20±9.5 62±14 
HIV+ 15±9 19±9 66±15 
HIV- 16±7 21±10 61±13 
 
Figure 17: Energy % of Macronutrients 
 
 
Dietary Fibre 
In lactating women the dietary fibre intake should be 30 g/d [D- A- CH; 2001]. 
Within the total group of this study the daily fibre intake was 22±21 g/d (Table 
12), ranging from 2- 54 g/d. 
Within the HIV positive group the dietary fibre intake was 19±13 g/d (min.: 2 g/d; 
max.: 54 g/d). In the HIV negative group the mean fibre consumption per day 
was 24±11 g/d (min.: 9 g/d; max.: 54 g/d).  
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Vitamins and Minerals 
It should be noted, that HIV positive women had lower micronutrient intakes 
than HIV negative women (Table 13). The mean intake of total folic acid was 
not even half of the recommended (600 µg/d) level (HIV+: 149±97 µg/d; HIV-: 
249±169 µg/d). Although it is a policy of the Kenyan government for women to 
be given folic acid supplement, only 46.7% received at least a combination of 
supplements with folate or folate on its own [KAMAU- MBUTHIA, 2006].  
 
Also the iron intake was low (HIV+: 8±5 mg/d; HIV-: 13±6 mg/d). Like in Zn 
intake, the iron bioavailability was limited by the high plant food sources. On the 
one hand fiber and phytate hinder the iron uptake and on the other hand the 
bioavailability was limited by the consumption of non-heme iron from plants. 
 
Table 14: Micronutrient intake assessed in a 24 Hour Recall 
Nutrient Total 
(mean±sd) 
HIV+ 
(mean±sd) 
HIV- 
(mean±sd) 
Recommend 
D- A- CH 
Total folic acid 
(µg) 
212 ± 154 149 ± 97 249 ± 169 600 
Vitamin C (mg) 86 ± 74 149 ± 58 102 ± 79 150 
Vitamin A (mg)* 1.6 ± 1.1 0.6 ± 0.5 1.6 ± 1.1 1.5 
Vitamin E (mg)** 10 ± 8 8 ± 7 11 ± 8 17 
Iron (mg) 11 ± 6 8 ± 5 13 ± 6 20 
Zinc (mg) 9 ± 5.6 7±4.5 10.3±6 11 
*1mg Retinol- aequivalent = 1 mg Retinol 
**1 mg RRR - - Tocopherol- aequivalent = 1 mg RRR-  -Tocopherol = 1.49 IE 
 
 
In both, the HIV positive and HIV negative group, the intake of Vitamin C (HIV+: 
149±58 mg/d; HIV-: 102±79 mg/d) and Vitamin E (HIV+: 8±7 mg/d; HIV-: 11±8 
mg/d) could not reach the recommended level.  
The Vitamin A intake was quite in the recommended range. In the HIV positive 
group the intake was 591±485 µg/d and within the HIV negative respondent 
group 1602±1141 µg/d. 
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The nutrient intake of the total respondents did not reach the recommended 
amounts in any nutrient. The HIV positive group’s nutrient intake was observed 
to be lower in all macronutrients and evaluated micronutrients. However, the 
differences between the investigated groups could not be assessed as 
significant. 
 
Zinc 
The mean Zn intake of all respondent women was 9±5.6 mg/d (min.: 1.4 mg/d; 
max.: 31.2 mg/d). The mean value of Zn intake within the positive group was 
7±4.5 mg/d (min.: 1.4 mg/d, max.: 17.1 mg/d) and within the HIV negative 
control group 10.3±6 mg/d (min.: 2.7 mg/d; max.: 31.2 mg/d) so the Zn intake of 
the HIV positive women was significant (p<0.01) lower than of negative lactating 
women. However, the recommended Zn intake of 11 mg/d could not be reached 
in both groups.  
The mean Zn intake in the HIV positive group was half as much than 
recommended. Within the HIV negative group the average Zn intake was 
slightly below, but close to the recommended value. 
A study of dietary patterns of pregnant women in an impoverished part of Lima 
in Peru reported about the same inadequate Zn intake like in this study [SACCO 
et al., 2003]. If it is taken into account, that HIV negative women do have a 
higher educational standard and a higher income, they are more likely to be 
able to effort better-balanced nutrition.  
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Figure 18: Zn Intake of Respondents (**: HIV+ <HIV-; p<0.01) 
 
 
The nutritional adequacy of dietary Zn depends on both, its amounts and 
bioavailability in the diet. In many developing countries, the content of flesh 
foods in rural diets is often low so that their contribution to total dietary Zn intake 
is small. Plant based diets often contain high levels of phytic acid and dietary 
fiber. Those components are known to inhibit the absorption of dietary Zn. The 
bioavailability of dietary Zn can be predicted from ratio of phytic acid to Zn in 
diets. The critical Phy: Zn molar ratios associated with risk of Zn deficiency are 
equivocal; ratios above 15 have been associated with biochemical and in some 
cases clinical signs of Zn deficiency in humans. Typical African dishes do have 
elevated Phy: Zn molar ratios (Table 15). 
 
Table 15: Zn and Food  
[Mod.:Ferguson et al., 1993] 
Food Zn [mg] Phy [mg] Phy: Zn [ratio] 
Rice and stew 0.6 118 21 
Rice and beans 0.5 107 18 
Gari and beans 0.9 178 22 
  ** 
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Groundnut soup 0.8 81 10 
All dishes plus tomatoes, red peppers, salt, onion, palm oil 
 
 
Water and liquid consumption 
Already 75% (HIV+: 43%; HIV-: 57%) of the study participants got their drinking 
water out of pipes, 9% (HIV+: 43%; HIV-: 57%) of all respondents obtained their 
water from boreholes, 6% (HIV+: 20%; HIV-: 80%) bought their water in shops, 
1% (HIV+: 100 %; HIV-: 0 %) got their water from a spring and 1% (HIV+: 0 %; 
HIV-: 100 %) from a river. 8% (HIV+: 33%; HIV-: 67%) stated other water 
supplies.  
 
The recommendation for water/liquid intake for lactating women is 2300 ml/d 
(equivalent g/d). Most of the women preferred drinking black tea with milk than 
pure water. 
Within the total respondent group the mean water/liquid intake (includes 
drinking water/liquid and water content in food) was 1571±691 g/d (min.: 483 
g/d; max.: 3102 g/d). The water/liquid intake in the HIV positive group was lower 
than in HIV negative group, but there is no statistical significance. The mean 
intake of HIV positive women was 1141±464 g/d (min.: 483 g/d; max.: 1914 g/d) 
and in the HIV negative group 1826±679 g/d (min.: 505 g/d; max.: 3102 g/d). 
None of the groups did reach the recommendation.  
 
Statements and Discussion: Nutritional Data 
In this study the daily energy intake of the participating women was lower 
(HIV+: 965.64±496 kcal < HIV-: 1363.09±627kcal; p<0.05) than the 
recommendation of 2850 kcal/d. The same situation was observed concerning 
the intake of protein (recommended: 63g/d; HIV+: 33±9 g/d; HIV- 55±37 g/d), fat 
(recommended: 30–35 E%; HIV+: 19±9E%; HIV-: 20±10) and dietary fibre 
(recommended: 30 g/d; HIV+: 19±13 g/d; HIV-: 24±11 g/d). The intake of 
carbohydrates was higher than the recommended amount (recommended: 50 
E%; HIV+: 65±15 E%; HIV-: 63±13 E%). It has to be stated that HIV negative 
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control group perform better or even has higher intakes (e.g. carbohydrates) 
than the recommended amount.  
 
In a study done in South Africa the energy intake of HIV positive women was 
significantly higher (p< 0.05; CI 95%) than in the HIV negative group. The mean 
intake of the total group exceeded the recommended dietary intakes. Fat was 
even higher than the recommendend 30 – 30% of the daily energy intake, 
dietary fiber was very low [HATTINGH et al., 2006] 
Data evaluated in this study indicated a very low intake of animal products and 
animal protein. Zinc and iron intakes were also quite low and additionally the 
bioavailability of these micronutrients is poor because of the high phytate, fiber 
and tea content of the typical diet.  
Further, vitamin B12 intake is extremely low, and at least mild-to-moderate iodine 
deficiency is reported to be present in Kenya. 
Results from the Collaborative Research Support Program (CRSP) reported of 
the highest predicted prevalence of inadequacy in developing countries for 
pregnant/ lactating women were iron, zinc, calcium, riboflavin, vitamin B-12, 
retinol and vitamin E. Animal source food are the main and most bioavailable 
source of these micronutrients in most diets and the inadequate intakes in the 
Nutrition CRSP were due to the low intakes of animal products. The percent of 
total energy from animal source food was only 18% in Egypt, 12% in Mexico 
and 8% in Kenya [NYAMBOSE et al., 2002]. 
 
4.2. Breastfeeding 
 
65% (HIV+: 39%; HIV-: 61%) of the recruited women chose exclusive 
breastfeeding and 35% (HIV+: 43%; HIV-: 57%) chose the mixed feeding 
(breastfeeding combined with formula feeding) option.  
In this study no significant differences between the frequency of chosen feeding 
options and the HIV status could be found.  
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Figure 19: Breastfeeding Option and Origin  
 
 
Statements and Discussion: Breastfeeding 
The pattern of adherence to exclusive infant feeding was similar to what has 
been found in other studies. Among women who maintained breastfeeding, a 
strong belief in the benefits of this feeding option and a supportive home 
environment was important [DOHERTY et al., 2006; OMARI et al., 2003]. 
Socioeconomic and infrastructural benefits like the availability of electricity, a 
kettle, a flask and formula food makes exclusive formula feeding interesting for 
HIV positive mothers. So women living in urban areas would have a profit 
because of the easier accessibility of the utensils for formula feeding (Figure19; 
Figure 20).  
It has to be noted, that with clearing up about HIV/ AIDS and the falling of 
stigmatization HIV positive women would be more encouraged to attend 
PMTCT (prevention of mother to child transmission) programs and to organize 
formula food for their babies. For these mothers formula feeding could get a 
properly alternative and probably contribute to minimize MTCT of the virus via 
breastfeeding. 
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4.4 Selenium – GSH-Px Activity 
 
For assessing the Se status in HIV positive and HIV negative women the 
erythrocyte GSH-Px activity was analyzed in the laboratory. The mean value 
within all women was at 24.01±7.21 U/g Hb (min.: 10.00 U/g Hb; max: 44.27 
U/g Hb). Within the HIV positive women the average activity of GSH-Px was 
25.21±8.30 U/g Hb (min.: 13.04 U/g Hb; max.: 44.27 U/g Hb), among the HIV 
negative control group the mean level was 22.85±6.53 U/g Hb (min.: 10.00 U/g 
Hb; max.: 38.00 U/g Hb) (Figure 21). 
There were no statistically significant differences between the seropositive and 
seronegative group and their assessed GSH-Px values. 
 
 
Figure 20: GSH- Px Activity of the Respondents 
 
 
22% (HIV+: 43%; HIV-: 57%) of all recruited women had a value lower than 18 
U/g Hb, 28% (HIV+: 25%; HIV-: 75%) were between 18.10- 23 U/g Hb, 20% 
(HIV+: 31%; HIV-: 69%) between 23.10-28 U/g Hb, 17% (HIV+: 50%; HIV-: 
50%) between 28.10- 30 U/g Hb and 13% (HIV+: 57%; HIV-: 43%) between 
30.10 and 35 U/g Hb.  
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Within the HIV positive almost a quarter (24%) had an GSH-Px activity under 
18.00 U/g Hb, 21% in the range of 18.10- 23 U/g Hb, 18% between 23.10- 28 
U/g Hb. 21% of the HIV positive subjects showed activities between 28.10- 31 
U/g Hb and 16% in the range of 31.10- 35 U/g Hb. 
In the HIV negative control 20% had lower enzyme activity levels than 18 U/g 
Hb, 35% ranged between 18.10- 23 U/g Hb, 22% between 23.10- 28 U/g Hb, 
14% had values between 28.10- 31 U/g Hb and 9% had GSH-Px activity levels 
between 31.10- 35 U/g Hb (Figure 22). 
The statistical distribution of the GSH-Px activities among the HIV positive 
participants did not significantly differ from that of the HIV negative subjects. 
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Figure 21: Erythrocyte GSH-Px activity (U/g Hb) 
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The normal range of GSH-Px activity should be between 18 and 25 U/g Hb 
[LOOK et al, 1997]. It has to be noted, that 20% of the HIV negative women had 
GSH-Px activities lower than 18 U/g Hb and in the HIV positive group the range 
of 18.1- 23 U/g Hb were the biggest group with 21%.  
Further evaluation of the data showed that the demographic origin (urban/rural) 
of a woman did not affect GSH-Px activity. The mean value in the total urban 
origin group was 18.84±11 U/g Hb (HIV+: 17.35±13 U/g Hb; HIV-: 19.76±10 U/g 
Hb) and within the rural origin group 19.77±13.83 U/g Hb (HIV+: 23.6±13.6 U/g 
Hb; HIV-: 14.6±13.5 U/g Hb) - no statistical significant differences could be 
observed between the HIV positive and HIV negative groups (Figure 23). 
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 Total (U/g Hb) HIV+ (U/g Hb) HIV- (U/g Hb) 
Rural 19.77±13.83 23.6±13.6 14.6±13.5 
Urban 18.84±11 17.35±13 19.76±10 
Figure 22: GSH-Px Activity of the Respondents living in different Areas 
 
 
In contrast to other investigations no correlations between age and GSH-Px 
activity could be identified in this study. However, there are studies indicating 
that HIV positive lactating women with a higher age, lower education and higher 
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parity have a higher plasma Se values, causing a higher GSH-Px activity levels 
in this group [DELMAS- BEAUVIEUX et al., 1996].  
 
In a study by KUPKA et al. [2004] among HIV infected pregnant women in sub- 
Saharan Africa, lower plasma selenium levels were associated with increased 
mortality and weakly with decreased CD+ 4 cell counts. 
 
SNOOK et al. [1987] reported neither of no correlation of Se and the mothers 
BMI nor with the infants’ birth weights.  
Some studies reported a significant dependence of the Se status from the area 
(urban/rural) where people are living. The Se contained in various plant derived 
foods depends on the Se soil content. In the region of Nakuru, Kenya, where 
this study was carried out soils are not poor of Se. So it can be assumed that 
crops and other plant foods contain an acceptable amount of this micronutrient. 
However it has to be noted that the food content is not equal to the 
bioavailability of Se (s. 2.4.4). Among different foods the highest Se content is 
found within intestines (0.4- 1.5 µg/g) and meat (0.1- 0.4 µg/g) but these foods 
are not primarily consumed by Kenyan women. Finally, there was no urban/rural 
influence on the Se status identified in this investigation. 
 
The mothers’ intake of Se is very important and has a big influence on the 
breast milk concentration. Coherence between demographic data and breast 
milk Se content is discussed controversial.  
VERTAINEN and KANTOLA [2001] reported a significant difference in breast 
milk Se concentrations between rural and urban Finnish mothers. Like in this 
investigation SNOOK et al. [1987] did not observe a significant difference in milk 
Se between rural and urban mothers. 
 
No significant correlation was found between the state of health and GSH-Px 
activity. There was no significant correlation found between the positive status 
of the baby, the origin of the HIV positive mother, her income and her GSH-Px 
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activity. Within the HIV positive group was no significant correlation found 
between GSH- Px and the HIV status of the child.  
 
4.2. Zinc – SOD Activity 
 
For Zn assessment, laboratory analyses of erythrocyte SOD activity were done.  
The mean value within all women was at 1005.2±253.5 U/g Hb (min.: 593.4 U/g 
Hb; max: 1969.5 U/g Hb). The mean value within the HIV positive women was 
939.5±217.3U/g Hb (min.: 593.4 U/g Hb; max.: 1677.7 U/g Hb). The mean value 
in the HIV negative control group was 1075.4±256.1 U/g Hb (min.: 686.3 U/g 
Hb; max.: 1969.5 U/g Hb) (Figure 24).  
There was no statistical significant difference of the erythrocyte SOD activity 
between HIV positive and negative respondents. 
 
 
Figure 23: SOD Activity of the Respondents 
 
 
59% (HIV+: 52%; HIV-: 48%) of all recruited women had a SOD activity lower 
than 1000 U/g Hb, 28% (HIV+: 29%; HIV-: 71%) between 1001- 1350 U/g Hb, 
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11% (HIV+: 29%; HIV-: 71%) between 1351- 1700 U/g Hb and 2% (HIV+: 0 %; 
HIV-: 100 %) between 1701- 2000 U/g Hb.  
Within the HIV positive three quarter (75%) of the respondents had an enzyme 
activity under 1000 U/g Hb, 19% in the range of 1001- 1350 U/g Hb, and 6% 
between 1351- 1700 U/g Hb. In none of the HIV positive women SOD activity 
reached the level of 1700 U/g Hb.  
More than half (59%) of the HIV negative recruited women had levels below 
1000 U/g Hb, 34% had levels between 1001- 1350 U/g Hb, 13% were between 
1351- 1700 U/g Hb, and 4% had values over 1700 U/g Hb (Figure 25).  
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Figure 24: Erythrocyte SOD activity (U/g Hb) 
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GUEMOURI L et al [1991] fixed the normal range for erythrocyte SOD activity 
between 1000-1700 U/g Hb.  
In this study, 59% of all women, 75 % of the HIV positive group and almost half 
(49%) of the HIV negative subjects had enzyme activity levels below the value 
of 1000 U/g Hb.  
 
There was no significant correlation between Zn intake and erythrocyte SOD 
activity.  
 
In reference to age, a significant positive correlation (r= 0.099, p< 0.05) 
between the HIV status and SOD activity could be found in this investigation. 
Among the HIV negative control group no significant correlation of these 
parameters were observed. 
 
Moreover the evaluation of the data showed a statistical significant correlation 
(r=0.018, p< 0.05) between SOD activity and origin (urban, rural, out of town, 
peri- urban). Women living in rural areas (1121±339.6 U/g H) had a significant 
(p<0.05) higher SOD activity than women living in an urban area (918.6±322.2 
U/g Hb) (Figure. 26). 
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 Total (U/g Hb) HIV+ (U/g Hb) HIV- (U/g Hb) 
Rural 1121±339.6 1012.4±299 1265.8±361.5 
Urban 918.6±322.2 886.4±178.7 938.67±386 
 
Figure 25: SOD Activity of the Respondents living in different Areas 
 
 
Most of the women living in rural areas have to plant their own vegetables and 
keep animals, like cows and chicken for feeding the whole family. Women in 
urban areas need more money to get a well balanced diet and most of the 
interviewed women did not have enough money to provide adequate nutrition 
for themselves. However, no significant correlation between income and SOD 
activity could be found. 
 
There was no significant correlation between the state of health and SOD 
activity and no significant relationship between SOD activity of the HIV positive 
mothers and the HIV status of the breast fed children. Further, no significant 
correlation between SOD activity, origin of the HIV positive mother and the risk 
of MTCT could be observed. Worth mentioning is, that HIV positive mothers 
with HIV positive infants do have SOD activities lower than 1000 U/g Hb. 
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5. Conclusion and Recommendation 
 
 
The study shows, that HIV/ AIDS exists irrespective of age, education, social 
class and demographic origin. There are differences between the infected and 
uninfected women for sociodemographic characteristics, anthropometrical and 
nutritional data, SOD and GSH-Px activity. HIV positive women do not live in 
matrimony than HIV negative women, are not that well educated and are not 
their food supply is not that good- although HIV negative lactating mothers in 
Nakuru are also not very well supplied with micro- and macronutrients. 
 
The evaluation of nutrient intake data (according to 24-h-recalls) clearly 
indicated that a majority of the study participants were malnourished. The 
required energy intake did not reach the recommended daily amount. Lactating 
and HIV positive women do need extra energy- on the one hand they use 
energy for producing milk and on the other hand their body needs energy to 
strengthen their immune system and to fight against the HI virus. Moreover, the 
micronutrient intake of the investigated subjects was generally too low. The 
recommended daily intake neither of vitamin C, iron and total folic acid nor of 
vitamin E or Zn were reached- in the HIV positive and HIV negative group. 
Interventions for improving the women’s nutrient intake and their health status 
should be an overall strategy, regardless whether the women are HIV negative 
or HIV positive. Due to the low educational status, especially within the HIV 
positive group, just an advice to eat more wouldn’t be useful. A follow- up 
teaching programme would be helpful, where childbearing women learn how to 
optimize their nutritional status by choosing the right food composition e.g. Se 
and Zn uptake will be supported by eating proteins (meat) and lowered by high 
phytate concentrations (green leafs).  
 
Consumption of more high quality foods, including animal source food, has the 
benefit of increasing the intake of many nutrients simultaneously. Some of these 
nutrients, as well as other bioactive constituents of foods, would not be provided 
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in either supplementation or fortification programs. All household members 
could benefit from improved household dietary quality, unlike supplementation 
programs, which are usually confined to women and young children, and 
fortification programs that may not reach the most needy population groups. 
 
Low intakes of macro- and micronutrients and low BMI values of HIV positive 
mothers are a problem and an additional risk factor for morbidity, mortality and 
MTCT. In Tanzania, maternal multivitamin (vitamins B, C, and E) 
supplementation reduced the risk of HIV transmission via breastfeeding among 
women who were nutritionally and immunologically compromised, and had 
additional health benefits such as a decreased incidence of fetal loss and a 
reduced rate of maternal disease progression [FAWZI et al., 2001]. Especially in 
HIV positive women malnourishment can lead to an inactive immune system 
and opportunistic infections are more common. It would be very useful to teach 
and show the women how to enrich their daily diet with “extra energy” without 
spending more money. 
 
Most of the study participants choose exclusive breastfeeding, because the 
women in countries like Kenya do not have clean water out of the tap, the 
utensils and the money for infant formula food. Breastfeeding is also the 
“easier” way, because most of them have to go back to work e.g. farm their 
fields or leave the infants with their housemaids.  
In this study it could be shown that the decision for an exclusive feeding option 
whether breast feeding or formula feeding depends on the fully informed 
parents and has to be promoted. For the infants development it is not very 
useful to mix different feeding options because of its proposed adverse effects 
on the mucosal integrity and its increased risk of MTCT.  
The adoption of formula feeding is not widespread in developing regions such 
as sub-Saharan Africa, partly due to its high cost and partly due to the social 
stigma associated with not breastfeeding. Further, in settings where access to 
adequate hygienic conditions is limited, formula feeding may lead to increased 
infant morbidity and mortality. 
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No clear coherence between MTCT and Se and Zn could be found in this study. 
Thus the HIV negative group was slightly better provided with Zn than the HIV 
negative group. The amount of Se and Zn intake depends, as already stated 
before, on the Se and Zn soil concentration. In the area of Nakuru, Rift Valley 
no Se/Zn poor soil is known by local agrarian scientist. However, it has to be 
taken into account, that Se/Zn intake is not the same as Se/Zn bioavailability. 
Finally it has to be noted, that a lack of Zn and Se supply respectively, is not 
just a HIV/AIDS problem in Kenya it is a problem of the whole female 
population. 
 
Although the results of this study could not identify a clear coherence between 
MTCT and the status of Se and Zn, other studies [BAUM MK et al., 1995; 
NDUATI RW et al., 1995; SEMBA RD et al., 1999] showed connections within 
these three parameters. An intervention study with a higher respondent number 
and carried out over a longer period of time would give more and concrete 
information about the coherence between MTCT, Se and Zn. Much more 
factors (e.g. CD+4 count, viral load of the mother, HIV status of the infant after 
delivery) which depend on Se and Zn have to be assessed and discussed. 
Further research is warranted to investigate the role of other nutrients in vertical 
HIV transmission via breastfeeding and overall maternal and infant health 
among HIV-infected breastfeeding women and their children. 
Finally it can be concluded that in Kenya a lot of information work about the 
necessity of nutrition has to be done in the future, whether the persons 
concerned are HIV positive or HIV negative.  
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6. Summary 
 
In developing countries an estimated 1.2 billion people live with less than 2 € a 
day. In the last years another threat joined famine and thirst: AIDS. In the 
previous ten years the acquired immunodeficiency syndrome became a deadly 
hazard for the people and their countries economic situation.  
 
In May and June 2008 a study was done in the Provincial General Hospital 
Nakuru, Rift Valley. The coherence between the maternal nutritional status of 
Zn/ Se and the MTCT of HIV was assessed. 79 lactating women (HIV+: 32; 
HIV-: 47) took part. The respondents had to answer questions about nutrition 
and health, 24 hour Recalls were done and the women had to give 5 ml venal 
blood for laboratory analysis.  
 
The women nutritional status is not satifactory. Both in macronutrients and 
micronutrients, they do not reach the recommended intakes. Especially the 
energy intake is alarmingly (recommended: 2850 kcal; mean intake: 
2020.15±609 kcal.  
 
By assessing SOD and GSH-Px activity, conclusions about the functional status 
of Zn and Se could be done. In general all women are quite low in Zn and Se, 
no matter if the respondent was HIV positive or HIV negative. The mean value 
of SOD activity within the HIV positive group was 939.5±217.3 U/g Hb, among 
the HIV negative respondents 1075.4±256.1 U/g Hb (recommendation: 1000 - 
1700 U/ g Hb). Within the HIV positive group the mean GSH-Px activity value 
was 25.21±8.3 U/g Hb and within the HIV negative group 22.85±6.53 U/g Hb 
(recommendation: 25 – 32 U/g Hb).  
No significant differences were observed between the HIV positive and negative 
groups. Further, it could be found that origin (urban/ rural), education and 
maritial status did not have an influence on the activity levels of both enzymes 
and the Se and Zn status, respectively. 
 
SUMMARY 
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No reference to coherence between MTCT of HIV and Se/ Zn could be found.  
It has to be noted, that follow up nutritional advices – for both, HIV positive and 
HIV negative women – would be necessary, to provide adequate nutritional 
supply.  
ZUSAMMENFASSUNG 
 74 
7. Zusammenfassung 
 
In den Ländern der 3. Welt leben schätzungsweise 1,2 Milliarden Menschen mit 
weniger als 2 € pro Tag. In den vergangene Jahren gesellte sich zu Hunger und 
Durst eine weitere Gefahr: AIDS. Das erworbene Immundefizienz Syndrom 
bekam in den letzten 10 Jahren eine tödliche Gefahr für den Menschen und 
bedeutet gleichzeitig einen wirtschaftlichen Rückschlag.  
 
Im Provincial General Hospital Nakuru, Rift Valley, wurden im Mai und Juni 
2008 eine Studie durchgeführt, bei der die HIV Übertragung von der Mutter auf 
das gestillte Kind in Abhängigkeit von deren Zink- und Selenversorgung 
untersucht wurde. 79 stillende Frauen (HIV+: 32; HIV-: 47) nahmen Teil. Die 
Probandinnen hatten Fragen zum Thema Ernährung und Gesundheit zu 
beantworten, ein 24 Stunden Ernährungsprotokoll wurde erstellt und je 5 ml 
venöses Blut wurden abgenommen.  
 
Der Ernährungszustand der Frauen kann im Gesamten als nicht 
zufriedenstellend beurteilt werden. Sowohl im Makronährstoffbereich, als auch 
im Mikronährstoffbereich wurde die empfohlene tägliche Zufuhr nicht erreicht. 
Alarmierend ist die geringe Energieaufnahme- die Empfehlung liegt bei 2800 
kcal, die Aufnahme bei 2020.15±609 kcal.  
 
Mithilfe der Messung der SOD Aktivität und der GSH- Px Aktivität konnten 
Rückschlüsse auf die funktionelle Versorgung von Zn und Se getroffen werden. 
Prinzipiell kann gesagt werden, dass sowohl die Gruppe der HIV positiven als 
auch die Gruppe der HIV negativen Frauen ungenügend mit Zink und Selen 
versorgt sind. Die durchschnittliche Aktivität von SOD lag innerhalb der HIV 
positiven Frauen bei 939.5±217.3U/g Hb und innerhalb der HIV negativen 
Frauen bei 1075.4±256.1 U/g Hb (Soll: 1000- 1700 U/ g Hb). Die Se 
Versorgung unterscheidet sich nicht wesentlich von der der Zn Versorgung. 
Innerhalb der HIV positiven Gruppe liegen die Werte bei 25,21±8.30 U/g Hb und 
in der HIV negativen Gruppe bei 22,85±6.53 U/g Hb (Soll: 25 – 32 U/g Hb). 
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In dieser Studie gibt es keine Hinweise auf einen Zusammenhang zwischen 
MTCT von HIV und Selen/ Zink. Grundsätzlich muss gesagt werden, dass 
begleitenden Ernährungsaufklärung, sowohl für HIV positive als auch HIV 
negative Frauen nötig ist, um den nicht ausreichenden Ernährungszustand 
sowohl im Makro- als auch im Mikronährstoffbereich zu verbessern.  
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